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Abbreviation key 
AGS   human gastric adenocarcinoma cell line  
BabA   blood group antigen-binding adhesin  
BHI  Brain Heart Infusion 
bp  base pair  
cagA   cytotoxin-associated gene A  
CagA   cytotoxin-associated protein A  
cag PAI  cytotoxin-associated gene pathogenicity island  
CFU  colony forming units 
CGC  corpus greater curve 
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COX-2  cyclooxygenase 2  
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HP-NAP  H. pylori neutrophil-activating protein  
HpaA   H. pylori adhesin A  
HRP  horseradish-peroxidase 
Hsp   heat-shock protein  
ICA  immunochromatography 
iceA  induced by contact with epithelium coding gene 
IFN   interferon  
Ig   immunoglobulin  
IHC  immunohistochemical 
IL  interleukin  
IRMS  isotope ratio mass spectrometry 
kDa   kilo Dalton  
Le   Lewis  
MALT  mucosa-associated lymphoid tissue  
MLST  multilocus sequencing typing  
mRNA  messenger RNA  
min  minutes 
napA   neutrophil-activating protein coding gene 
NapA   neutrophil-activating protein  
NF-κB  nuclear factor κB  
NHPH  non-H. pylori Helicobacter  
OipA   outer inflammatory protein A  
    
OMP   outer membrane protein  
ON  overnight 
PAGE   polyacrylamide gel electrophoresis  
PBS  phosphate-buffered saline 
PCR   polymerase chain reaction 
PMA  propidium monoazide  
PG  pepsinogen 
PPI  proton pump inhibitor 
qPCR   quantitative real-time PCR  
r   recombinant  
RHG  rugal hyperplastic gastritis 
RT  Real-time 
ROS   reactive oxygen species  
rRNA   ribosomal RNA  
RUT  rapid urease test 
SabA/B  sialic acid-binding adhesin A/B 
SAT  stool antigen test 
SDS   sodium dodecyl sulfate   
STs  sequence types 
Th   T helper  
TNF   tumor necrosis factor  
TLR   Toll-like receptor  
Treg   regulatory T cell  
UBT  urea breath test 
UreA/B  urease subunit A/B  
VacA   vacuolating cytotoxin  
VBNC  viable-but-non-culturable 
W  Watt 
2D   two-dimensional 
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The present thesis deals with Helicobacter suis, a bacterium which is highly prevalent in pigs 
and can infect humans too, causing gastric disease. Research has been seriously hampered by 
the very fastidious nature of this microorganism and several fundamental questions remain 
open. In the general introduction, the nomenclature, clinical significance, epidemiology and 
diagnosis of gastric Helicobacter infections in humans and animals are described. 
Furthermore, a brief overview of the literature on the pathogenesis and the role of virulence 
factors is given. For a more comprehensive review regarding the virulence factors of gastric 
Helicobacter species we refer to Haesebrouck et al., 2009 and the general introduction of the 
thesis of Flahou, 2011 and Vermoote, 2013. 
 
In 1984, it was first reported that both gastritis and gastric ulcer disease in humans can be 
caused by a typical curved bacterium (Marshall and Warren, 1984). The organism was 
originally considered to be a member of the genus Campylobacter, but was later included in a 
new genus, Helicobacter, with the curved bacterium Helicobacter (H.) pylori being its first 
member (Goodwin et al., 1989).  
Meanwhile, this Gram-negative bacterium is known to play a key role in the development 
of even more severe upper gastrointestinal problems, eg. gastric adenocarcinoma and mucosa-
associated lymphoid tissue (MALT) lymphoma (Stolte et al., 1993; Kusters et al., 2006). 
Although the prevalence of H. pylori in the Western world is decreasing, gastric colonization 
by this organism remains widespread with prevalence rates of more than 80% in developing 
countries (Kusters, 2006). The human gastric mucosa is, however, able to harbor other 
Helicobacter species, besides H. pylori (Heilmann and Borchard, 1991). These non-H. pylori 
helicobacters (NHPH), including H. suis, are characterized by a typical spiral-shaped 
morphology, and have been detected in 0.2 to 6% of human gastric biopsies (Heilmann and 
Borchard 1991; Stolte et al., 1994; Svec et al., 2000; Solnick et al., 2003). In a recent study, 
the prevalence of H. suis infections was examined in Parkinson‟s disease patients (Blaecher et 
al., 2013). H. suis DNA was found in gastric biopsies from 12% of Parkinson‟s disease 
patients, but only in 0.6% of controls. The significantly higher frequency of H. suis infections 
in patients with parkinsonism, might explain the higher prevalence of Parkinson‟s disease 
among farmers. To which extend H. suis infections can be associated with this disease is 
however still unclear, and remains the subject of future studies. 
The spiral shaped NHPH were originally named “Gastrospirillum hominis” (Mc Nulty et 
al., 1989). After analysis of the 16S rRNA gene, this initial name was replaced by 
“Helicobacter heilmannii” (Heilmann and Borchard, 1991). Further research led to the 
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conclusion that these bacteria comprise more than one Helicobacter species, which are 
primarily associated with infections in animals (O‟Rourke et al., 2004; De Groote et al., 2005; 
Van den Bulck et al., 2005; Haesebrouck et al., 2009).  
Although H. pylori infections have occasionally been demonstrated in ruminants, cats and 
in an Australian marsupial, the stripefaced dunnart (Sminthopsis macroura) (Handt et al., 
1994; Every et al., 2011; Momtaz et al., 2014), animals are not considered to play an 
important role in the transmission of this bacterium to humans. Demonstration of H. pylori in 
cats and dunnarts may be related to an anecdotic anthroponosis. Moreover, it can not be 
excluded that in some of the ruminant cases not H. pylori itself was involved, but rather a 
bacterium closely related to this micro-organism (Haesebrouck et al., 2009). 
1. Gastric Helicobacter infections in humans and pigs  
1.1. Nomenclature and characteristics of gastric non-Helicobacter pylori Helicobacter 
species 
Since the identification of H. pylori, many other helicobacters have been described. Although 
many, if not all, of these “other” helicobacters, are enzootic in animals, there is now 
accumulating evidence that several of these species can also cause disease in humans 
(Andersen et al., 1999; Jalava et al., 2001; Kivistö et al., 2010; Joosten et al., 2013; 
Wüppenhorst, 2013). Since the onset of NHPH research, frequent changes in the 
nomenclature have been made, causing confusion among clinicians and bacteriologists. 
Subsequent to the proposal of the name H. heilmannii, further characterization of the 16S 
rRNA gene led to the subclassification into “H. heilmannii” type 1 and “H. heilmannii” type 2. 
“H. heilmannii” type 1 appeared to be, both morphologically and genetically, identical to H. 
suis, a bacterium colonizing the stomach of more than 60% of slaughter pigs (Mendes et al., 
1991; Grasso et al., 1996; De Groote et al., 1999; Park et al., 2004; Hellemans et al., 2007; 
Baele et al., 2008). This large spiral-shaped microorganism was provisionally named 
“Gastrospirillum suis” (Mendes et al., 1990). However, based on 16S rRNA gene sequencing, 
fluorescent in-situ hybridization (FISH) and electron microscopy, nearly ten years later it was 
accepted that this bacterium belongs to the genus Helicobacter and is sufficiently different 
from other species to constitute a new taxon. Since at that time no pure in vitro isolates were 
available, this species could not be further characterized and the organism was named 
“Candidatus Helicobacter suis” (De Groote et al., 1999). Only in 2008, a successful in vitro 
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cultivation method was developed, which led to the description of H. suis as a formal species 
name (Baele et al., 2008).  
“H. heilmannii” type 2, appeared not to represent one species, but actually comprises a 
group of species: H. felis, H. bizzozeronii, H. salomonis, H. cynogastricus, H. baculiformis 
and the “true” H. heilmannii, known as H. heilmannii sensu stricto (Haesebrouck et al., 2011). 
All of these species are known to primarily colonize the stomachs of cats and dogs, but 
humans can be infected as well.  
All NHPH species share their spiral-shaped morphology, and although morphological 
differences between the different species have been described, microscopic investigation is 
not an accurate method for species identification. H. felis, H. cynogastricus and H. 
bacculiformis are characterized by the presence of periplasmic fibrils (Figure 1A) (Eaton et al., 
1996; Van den Bulck et al., 2006; Baele et al., 2008). The first two species are both tightly 
coiled, whereas the latter is a large, slender, slightly spiral-shaped rod (Hänninen et al., 1996; 
Baele et al., 2008). H. salomonis, H. bizzozeronii, H. heilmannii and H. suis (Figure 1B) do 
not possess periplasmic fibrils and are all, except for H. salomonis, known to have very tight 
coils (Hänninen et al., 1996; Jalava et al., 1997; Baele et al., 2008; Smet et al., 2011). 
 
Figure 1: (A) Scanning electron micrograph of a H. felis strain, isolated from the gastric 
mucosa of an adult cat, showing multiple bipolar flagella and the characteristic periplasmic 
fibers. Bar: 1 μm. Adapted from Solnick and Schauer, 2001. Photo courtesy ofAdrian Lee, 
Jani O'Rourke, and Lucinda Thompson. (B) Negatively stained cell of H. suis strain HS1, 
presenting tightly coiled spirals with up to six turns, with bipolar flagellae. Periplasmic fibrils 
are not observed. Bar: 2 μm. Adapted from Baele et al., 2008. 
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1.2.Gastric non-H. pylori helicobacters in humans 
1.2.1. Clinical significance of gastric non-H. pylori helicobacters in humans 
In 1991, Heilmann and Borchard described the potential of other bacteria than H. pylori to 
colonize the human gastric mucosa. These organisms were found to be similar to the spiral 
shaped bacteria found in the stomachs of cats, dogs and non-human primates. Only several 
years later, the first human NHPH-strain was isolated in vitro from a gastric mucosa sample 
(Andersen et al. 1999). Analysis of the 16S rRNA gene sequence, DNA-DNA hybridization 
analysis and whole-cell protein profiling revealed that this isolate belonged to the species H. 
bizzozeronii (Jalava et al., 2001). Since then, only two other human NHPH-isolates were 
obtained, including another H. bizzozeronii strain, and a H. felis strain (Kivistö et al., 2010; 
Wüppenhorst, 2013).  
In comparison with H. pylori infections, NHPH-infections are rather rare (Stolte et al., 
1994; Boyanova et al, 2003; Yang et al., 1998; Yali et al., 1998; Ierardi et al., 2001; Yakoob 
et al., 2012). Therefore, H. pylori is still considered to be the major cause of chronic (atrophic) 
gastritis, peptic ulceration, gastric carcinoma and mucosa associated lymphoid tissue (MALT) 
lymphoma in humans. Furthermore, gastritis associated with NHPH infection is mostly less 
active than H. pylori-associated gastritis (Stolte et al., 1997; Joo et al., 2007). However, 
patients with NHPH gastritis develop more frequently MALT lymphoma than those with H. 
pylori gastritis (1.48% and 0.66% respectively) (Stolte et al., 1997; 2002).  
Coinfections with both H. pylori and NHPH have been described in human patients 
(De Groote et al., 2005; Van den Bulck et al., 2005; Yakoob et al., 2012; Liu et al., 2014). 
These coinfections mainly result in aspecific gastro-intestinal symptoms, such as vomiting, 
epigastric pain and dyspepsia (Ojano et al., 2012; Yakoob et al., 2012). The significance of 
co-infections in terms of disease development and severity still needs to be determined. 
1.2.2. Origin of infections and epidemiology 
Human infections with NHPH organisms most likely originate from animals, and although the 
exact routes of transmission remain uncertain, living in close proximity to dogs, cats and 
especially pigs is a significant risk factor (Meining et al., 1998). To gain further insight into 
the diversity of both human and porcine H. suis strains, a multilocus sequence typing (MLST) 
technique, based on 7 housekeeping genes (atpA, efp, mutY, ppa, trpC, yphC, and ureI), was 
developed (Liang et al., 2013). Assessment of the allelic profiles for 10 available H. suis 
isolates led to 10 distinct sequence types (STs). In addition, by applying the technique on 
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gastric biopsy specimens from a human patient and 17 slaughter pigs originating from 4 
different herds, 14 additional STs were distinguished and a close relationship was 
demonstrated between the human H. suis strain and porcine H. suis strains. This finding adds 
strength to the hypothesis that these infections indeed originate from animals. Since close 
contact with dogs and cats is more common than with pigs in Western society, it is 
remarkable for H. suis to be the most prevalent gastric NHPH species in humans (Trebesius et 
al., 2001; Van den Bulck et al., 2005). This higher prevalence might result from other routes 
of transmission, such as for example manipulation or consumption of raw or undercooked 
pork meat (as discussed in 1.2.3.). In addition, the ability of H. pylori to survive in common 
foods (Velàzquez and Feirtag, 1999; Quaglia et al., 2007) supports the hypothesis that 
primary contamination of a food product or secondary contamination due to inappropriate 
handling can form a vector for the transmission of Helicobacter bacteria.  
Waterborne transmission 
As epidemiological evidence supports the fecal-oral route for the transmission of H. pylori, 
fresh water might be the natural reservoir for this organism (Hopkins et al., 1993; Hulten et al., 
1996; Hegarty et al., 1999; Moreno et al., 2003). Using molecular methods, H. pylori has been 
detected in various water systems, including rivers, surface and shallow ground water, and 
sewage systems (Enroth and Engstrand, 1995; Hultén et al., 1998; Lu et al., 2002). Isolation 
procedures, on the other hand, have rarely been successful starting from these sources. These 
findings implicate that detection of H. pylori DNA in water samples not necessarily confirms 
viability or infectivity of the microorganism. Moreover, the existence of a viable-but-not-
culturable (VBNC)-state has frequently been the topic of debate (Shahamat et al., 1993). This 
state may correspond to the coccoid form, a state which the bacterium enters during in vitro 
experiments, when under stress and nutrient depletion (Adams et al., 2003). It has been 
demonstrated that the coccoid form of H. pylori remains viable, even though culturability is 
lost and no conversion from this state could be obtained in in vitro experiments. In the mouse 
model, reversion to an infective H. pylori form has been established when the coccoid form 
was inoculated intragastrically (Alejun et al., 1996). Adams and co-workers (2003) assessed 
the culturability and viability in cells incubated in both laboratory and a natural freshwater, 
using a LIVE/DEAD BacLight viability assay. During these studies, culturability of these 
cells was found to decline after ca. 10 days, although a large population of viable cells was 
still present. These results are consistent with data published for H. pylori and Campylobacter 
coli by other research groups (Benïssia et al., 1996; Boulos et al., 1999; Alonso et al., 2002). 
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Other studies report survival of H. pylori in sea and fresh water as culturable forms for several 
weeks and as non-culturable forms for up to a year (Shahamat et al., 1989; West et al., 1992; 
Konishi et al., 2007). Additional indirect evidence of the presence of H. pylori in water (used 
for irrigation) is the association of infections with the consumption of raw vegetables 
(Hopkins et al., 1993; Goodman et al., 1996; Chen et al., 2005; Mazari-Hiriart et al., 2008). 
In drinking water systems, micro-organisms such as Esherichia coli and 
Campylobacter spp., are predominantly associated with survival in the formed biofilms, rather 
than in the water itself (Mackerness et al., 1993; Buswell et al., 1998). Although several 
studies suggested that biofilms in water distribution systems may also harbor H. pylori 
organisms, culture from these biofilms has been unsuccessful and cell membranes did not 
remain intact (MacKay et al., 1999; Park et al., 2001; Azevedo et al. 2006; Giao et al., 2008). 
Transmission through invertebrate species  
The role of insects as a vector for H. pylori has been investigated in studies on houseflies and 
cockroaches. Not only have researchers been able to amplify H. pylori DNA from the 
abdomens of wild flies, transmission of H. pylori to sterile petri dishes by experimentally 
infected house flies (Musca domestica) has been determined for up to 30 hours as well 
(Grubel et al., 1997; 1998). However, H. pylori could not be recovered from wild flies which 
had been exposed to human feces (naturally or experimentally) infected with H. pylori (Osato 
et al., 1998). In a study focusing on the eradication of flies, the control of flies did not 
influence the H. pylori infection rates in an area of high prevalence, suggesting flies are 
unimportant in H. pylori transmission (Allen et al., 2004). The presence of cockroaches has 
been suggested to represent a mode of transmission in poor socioeconomic environments 
(Imamura et al., 2003). Indeed, H. pylori has been successfully cultured from the excrements 
of cockroaches for 24 hours and the detection of H. pylori DNA could be established for up to 
7 days after experimental exposure. The possible vector potential of insects for H. suis, or 
NHPH-infections in general, has not yet been investigated. 
Transmission through milk 
Since H. pylori DNA was detected in raw sheep milk, milk has been considered a possible 
source of infection for humans (Dore et al., 1999; Dore et al., 2001; Fujimura et al., 2002). In 
a Japanese study, H. pylori DNA was detected in up to 72.2% of raw cow milk samples 
(Fujimura et al., 2002). In a more recent Italian study, detection of the glmM gene was 
established in 25.6% of all investigated goat milk samples, 33% of sheep milk samples, and 
50% of cow milk samples (Quaglia et al., 2008). In this study, isolation procedures from the 
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samples were not successful, which might be attributed to the low number of bacteria present 
in the milk, to the presence of VBNC forms, or to the relatively long period of storage (up to 3 
days at 4°C). Survival of H. pylori in milk has been demonstrated in artificially contaminated 
milk for a longer period (Quaglia et al., 2007). Successful isolation of H. pylori from raw milk 
samples, however, remains rare (Dore et al., 1999; Dore et al., 2001; Fujimura et al., 2002). It 
was shown that the percentage of detection of H. pylori DNA decreases when two genes are 
assayed (Dore et al., 1999, 2001; Fujimura et al., 2002;Quaglia et al., 2008). Moreover, 
caution should be taken on the use of 16S rRNA to identify H. pylori. The genetic relationship 
among strains isolated from milk and human patients has not been characterized during these 
studies, by for instance performing MLST or whole-genome sequencing. In conclusion, in the 
majority of studies describing the presence of H. pylori in milk, it is not clear whether it was 
really H. pylori that was demonstrated or rather H. pylori-like organisms.  
1.2.3. The importance of contaminated pork carcasses and meat products 
At the start of this thesis, nothing was known concerning the presence and persistence of H. 
suis bacteria on pork carcasses or in pork meat. As previously stated, research is hampered by 
the low success rate of isolation procedures, rendering detection of live H. suis bacteria by 
culture-based methods not feasible. As a consequence, the contribution of food of animal 
origin to human infection with H. suis remained unclear. Therefore, critical points for carcass 
contamination along the slaughterline, which are of significant value in the control of known 
foodborne pathogens, will be described in the following section. 
Carcass contamination 
Critical points for pork carcass contamination are scalding, polishing, evisceration and meat 
inspection procedures (Borch et al., 1996). These steps, during which the carcasses, the 
slaughter equipment and environment can become contaminated, will be discussed in 
chronological order. After stunning, the animals are immediately stuck by cutting the main 
blood vessels in the chest and then bled over a trench. Each animal is then scalded for 4 min. 
(at 63°C) followed by immediate mechanical dehairing. Hald and co-workers (2003), showed 
a higher risk of carcass contamination with Salmonella if scalding water was Salmonella 
positive. After scalding, pigs are secured to the overhead conveyor by hooks behind the 
Achilles‟ tendons of both legs, after which the carcasses are singed and dry polished. Based 
on a literature review, Berends et al (1997) suggested that 5-15% of Salmonella carcass 
contamination occurs during polishing. Moreover, a positive correlation between the 
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contamination level of the carcass immediately after polishing and the contamination level of 
the carcasses after splitting and forced chilling was observed (De Busser et al., 2011). 
Wringing of the carcasses at this step and the difficulty of cleaning of equipment, might allow 
bacteria to establish on the surface of the brushes and scrapes (Borch et al., 1996). Adding a 
second singeing device, after polishing, is helpful in avoiding contaminated carcasses to enter 
the clean part of the slaughterhouse (Delhalle et al., 2008; De Sadeleer et al., 2009; De Busser 
et al., 2011). After this step, carcasses are given a pre-evisceration wash with potable warm 
water. Evisceration is performed by first detaching and bagging the anus and rectum, followed 
by splitting the belly and manually removing the diaphragm, heart, lungs, trachea and tongue 
along with the digestive tract. Studies show between 55 and 90% of all carcass contamination 
with Salmonella occurs during the evisceration step (Berends et al., 1997). Fasting of the pigs, 
correct evisceration techniques and proper training of slaughterhouse personnel are effective 
measures in diminishing the risk of accidental cutting through the intestines. Subsequently, 
carcasses are cut along the midline using an automatic splitting saw. The splitting saw can 
also cause cross-contamination of carcasses (Swanenburg et al., 2001; Bertrand et al., 2010; 
Smid et al., 2012). Cleaning and disinfection of the saw, several times a day, was shown to be 
beneficial in reducing Salmonella contamination (Delhalle et al., 2008). Meat inspection 
procedures concerning the carcass head (eg. inspection of the submaxillary lymph nodes) also 
seem to represent a risk for contamination, as well as splitting of the head (Andersen, 1988; 
Nesbakken et al., 2003). It seems plausible that organisms colonizing the stomach (such as H. 
suis) might contaminate the oral cavity, and generate cross-contamination by the splitting saw 
after reaching the head. Finally, the carcasses are (most often) first schock-chilled for 75 min 
by forced ventilation, and then stored in cooling rooms at 3°C for at least 24h. Van Driessche 
and co-workers (2007) reported that, although cooling combined with drying of the surface of 
the carcasses reduced the number of positive areas on the carcasses, no effective elimination 
was established. Similar observations have been made in Campylobacter research in pig 
slaughterhouses (Oosterom et al., 1985; Epling et al., 1993).  
Other factors that should be taken into account are contamination through the hands of 
the slaughterhouse personnel and meat inspectors and the processing water (Houf et al., 2002; 
Gude et al., 2005; Vieira-Pinto et al., 2006; Bertrand et al., 2010; Duggan et al., 2010).  
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Detection of foodborne pathogens in processed meat samples 
In order to determine whether processed pork meat constitutes a possible source of H. suis 
infections to humans, detection methods need to be developed. Although culture methods are 
labour-intensive and time-consuming, which is not desirable in cases when urgent diagnosis is 
necessary or when many samples have to be tested, these methods are still recommended for 
pathogens such as Salmonella. As previously stated, culture-based methods for the detection 
of H. suis bacteria in food are not feasible. Therefore, more convenient, and reliable 
alternatives could be the goal of future research. 
Real-time (RT-)PCR for instance, is the most common approach in rapid testing, 
characterized by an even higher sensitivity and specificity than regular PCR methods (Hoorfar, 
2011). A major disadvantage of PCR-methods (classic or Real-time), is that no distinction can 
be made between DNA derived from live or dead bacterial cells. This limitation has been 
overcome by the development of an ethidium monoazide (EMA) or propidium monoazide 
(PMA)-PCR method (Nogva et al., 2003; Nocker et al., 2006). By treating bacterial samples 
with EMA, prior to PCR, only DNA from viable cells is amplified, since EMA selectively 
binds to DNA of dead cells. Since the first description of this detection method by Nogva and 
co-workers (2003), multiple optimizations have been described for various microorganisms 
(Rueckert et al., 2005; Nam et al., 2011; Qin et al., 2012). 
1.3.Gastric non-H. pylori helicobacters in pigs 
1.3.1. Prevalence and epidemiology of H. suis infections in pigs 
Back in 1990, the role of pigs as a possible reservoir for (H.) pylori-like organisms was 
studied (Queiroz et al., 1990). However, instead of H. pylori-like organisms, not previously 
described Gram negative, large spiral-shaped bacteria were found in the mucus layer of the 
lumen and antral pits of porcine stomachs. These bacteria are nowadays known as H. suis. H. 
suis is a worldwide spread bacterium, often colonizing the stomach of pigs. Prevalence rates 
range from 8% to 95%, depending on the study, though most reports state a prevalence of 60% 
or higher at slaughter age (Barbosa et al., 1995; Grasso et al., 1996; Cantet et al., 1999; 
Roosendaal et al., 2000; Choi et al., 2001; Hellemans et al., 2007; Kopta et al., 2010). 
Prevalence rates not only depend on the geographical region, but also on the age of the 
animals (Hellemans et al., 2007; Kopta et al., 2010). The high prevalence of infection in adult 
pigs suggests that H. suis persists in adult pigs, indicating that the natural immune response 
against H. suis does not lead to its clearance from the stomach.  
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Opposed to a very high prevalence in adult animals, the frequency of H. suis infection 
in young pigs is much lower: only 2% in suckling piglets (Hellemans et al., 2007). A very 
rapid increase in the prevalence was observed after weaning, suggesting a possible maternal 
protection of the sow milk. The protective effect of (human and mouse) mother milk has also 
been shown for H. pylori (Corthésy-Theulaz et al., 2003; Bhuiyan et al., 2010).  
1.3.2. H. suis infections and porcine gastric pathology  
The stomach mucosa of pigs can be divided in a glandular and a non-glandular part, with the 
glandular part consisting of the cardia, fundus and antrum, and the non-glandular part the pars 
oesophagea (Figure 2). Together with the cardiac gland zone, the pars oesophagea represents 
almost 50% of the stomach, and both have a pH range between 5 and 7 due to the presence of 
saliva and bicarbonate from the cardiac glands (Höller, 1970). The pars oesophagea is a small 
rectangular region surrounding the oesophageal opening, which is covered with stratified 
squamous epithelium and shows no mucus secretion (Friendship, 2006). As a consequence, 
only limited protection against low pH and gastric enzymes is ensured in this region. The 
distal, or glandular, compartment ensures postprandial digestive enzymatic activity due to 
acid secretion, maintaining a low pH in this region, which is necessary for pepsin activity. 
 
Figure 2: Schematic overview of the stomach mucosa of pigs, with C. the cardia; P. the 
pylorus; 1. the pars non-glandularis; 2. the cardiac gland region; 3. the fundic gland region; 4. 
the pyloric region; 5. the gastro-duodenal transition.  
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Both in naturally and experimentally infected pigs, H. suis infections have been 
associated with chronic gastritis, mainly located in the antrum (Mendes et al., 1991; Queiroz 
et al., 1996; Park et al., 2000; Hellemans et al., 2007; De Bruyne et al., 2012). Gastric 
ulcerations, however, typically appear in the pars oesophagea. Certain predisposing factors 
would lie at the basis of ulcer development. Their presence would lead to a disruption of the 
segregation of the proximal and distal compartment, with loss of the distinct pH and 
enzymatic conditions. As a result, the mucosa of the pars oesophagea is exposed to 
increasingly acidic conditions, which can lead to epithelial insults, followed by hyperkeratosis, 
erosion, and finally, ulceration (Friendship, 2006). Possible predisposing factors are: particle 
size of feed (pelleting and fine grinding of feed), the presence of short chain fatty acids in the 
stomach, concurrent diseases leading to decreased food intake and stress (Hessing et al., 1992; 
Argenzio et al., 1996; Ayles et al., 1996; Robertson et al., 2002; Amory et al., 2006; Millet et 
al., 2012). Some studies also report an association of H. suis with gastric ulcers (Barbosa et al., 
1995; Queiroz et al., 1996; Roosendaal et al., 2000; Choi et al., 2001; Appino et al., 2006; 
Krakowka and Ellis, 2006; Proietti et al., 2010). In contrast, other research groups did not find 
this association, leaving the exact role of H. suis in the development of porcine gastric ulcers 
unclear (Grasso et al., 1996; Melnichouk et al., 1999; Park et al., 2000; Szeredi et al., 2005).  
It has been suggested that H. suis can increase the number of endocrine gastrin-
producing cells, and decrease the number of somatostatin-producing cells (Sapierzyński et al., 
2007). Additionally, H. suis was found in close contact with parietal cells of the fundic region 
of experimentally H. suis infected pigs, which might indicate that the bacterium may have an 
impact on these HCl-producing cells (Hellemans et al., 2007). As a result, a higher production 
of hydrochloric acid (HCl) might occur, which in turn may lead to increased contact of the 
non-glandular part with HCl and may result in the development of ulcers. Another possibility 
is that H. suis does not act as a primary cause of ulcers, but instead causes a delay in healing 
(De Bruyne et al., 2012). 
2. Virulence factors of gastric Helicobacter species 
Until recently, very little was known about virulence factors of non-H.pylori helicobacters. 
Most research concerning virulence mechanisms has been realized with H. pylori. Therefore, 
the main focus in the next section will lie on this microorganism, mentioning possible 
similarities and differences for the NHPH virulence factors. In table 2, H. pylori virulence-
associated genes are presented for which homologues were detected in the genomes of H. 
heilmannii, H. suis, H. felis and H. bizzozeronii. 
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2.1. Virulence factors involved in gastric colonization and persistence 
Several virulence factors are considered to play a role in colonization and persistence of H. 
pylori in the stomach. These enzymes and proteins include the urease cluster protein, alpha 
carbonic anhydrase, sheated flagella, the pH taxis tlpB gene, arginase and several adhesins 
and outer membrane proteins.  
All gastric helicobacters possess a family of genes encoding the urease enzyme 
(Burne and Chen, 2000). This enzyme consists of two subunits, UreA and UreB, and forms an 
essential component of H. pylori acid resistance, by converting urea into ammonia and carbon 
dioxide. The ammonia neutralizes the hydrochloric acid of the stomach, which results in an 
increase of the pH. Urease activity is regulated by different parameters, including the pH itself, 
as well as the availability of urea and nickel (Eaton et al., 1991; Tsuda et al., 1994; Karita et 
al., 1995). The urease gene cluster includes a second operon, downstream of the ureAB genes, 
comprising ureI and the urease accessory ureEFGH genes (Akada et al., 2000). The 
UreEFGH proteins probably function in the subunit assembly and the regulation of urease 
activity by the incorporation of nickel (Cussac et al., 1992; Mobley et al., 1995). The UreI 
protein functions as an acid-activated urea channel, which controls the urea transport into the 
cell (Scott et al., 2000). Apart from genes of the urease complex, the hydrogenase accessory 
proteins HypA and HypB have been shown to be important for a good urease activity (Olson 
et al., 2001). 
Next to the acidic environment, gastric helicobacters have to counteract oxidative 
stress, produced by the active immune response. H. pylori expresses several key components 
such as catalase, (KatA) superoxide dismutase (SodB) and alkyl hydroperoxide reductase 
(AhpC) (Seyler et al., 2001; Harris et al., 2002; Olczak et al., 2003; Barnard et al., 2004; Ernst 
et al., 2005). In addition, antioxidant proteins were described, including the H. pylori 
neutrophil-activating protein, HP-NAP (Wang et al., 2006). HP-NAP has a role in both 
inducing and combating oxidative stress resistance. The protein is thought to protect DNA 
from the detrimental effects of reactive oxygen species (Olczak et al., 2003; Barnard et al., 
2004). On the other hand, HP-NAP is also implicated in the activation of neutrophils, leading 
to the formation of reactive oxygen species (Evans et al., 1995).  
Motility is another essential characteristic for stomach colonization, which in this case, 
allows Helicobacter species to move toward a more neutral pH (Evans and Evans, 1995). 
Helicobacter species are motile by the presence of flagellae, which consist of a body, hook 
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and flagellar filament. Each filament, in turn, is composed of two flagellins, flagellin A (FlaA) 
(encoded by the flaA gene) and flagellin B (FlaB) (encoded by the flaB gene). Other genes, 
known to be essential in flagellar structure and motility include flgE and fliD, encoding the 
flagellar hook and flagellar cap proteins respectively (O‟Toole et al., 1994; Kim et al., 1999). 
Experiments in different animal models with H. pylori, H. felis and H. mustelae illustrated the 
need for flagellar motility to colonize the stomach (Eaton et al., 1992; Josenhans et al., 1999; 
Ottemann and Lowenthal, 2002). H. mustelae mutants defective in hook production, H. 
mustelae flaA and flaB double mutants and flgE and fliD mutants are nonmotile, whereas 
single flaA and flaB mutants show a decreased motility, still enabling the microorganism to 
colonize and persist in the ferret‟s stomach (O‟Toole et al., 1994; Josenhans et al., 1995; 
Andrutis et al., 1997; Kim et al, 1999). 
In addition to motility, chemotactic behavior of H. pylori has been indicated by 
several studies (Foynes et al, 2000; McGee et al., 2005; Terry et al., 2005). The 
microorganism shows a directed motility towards urea, bicarbonate, cholesterol, arginine and 
other amino acids, but moves away from hydrochloric acid (O‟Toole et al., 1994; Kim et al., 
1999; Lertsethtakarn et al., 2011). For the latter, the pH taxis, the chemotaxis receptor TlpB is 
required. Moreover, tlpB mutants are defective for mouse colonization. 
Several adhesins and outer membrane proteins are involved in the adhesion of H. 
pylori to the gastric epithelium. There are five families of outer membrane proteins (OMPs) 
for H. pylori: the major OMP family consisting of Hop and Hor proteins, the Hof protein 
family, the Hom protein family, the iron-regulated OMPs and the efflux pump OMPs. The 
large number of H. pylori adhesins probably reflects the importance of these proteins for the 
microorganism, but makes it difficult to examine the true contribution of each adhesin. 
Therefore, a summary of the most important adhesins and their primary role in virulence is 
given (Table 1), rather than a complete overview. 
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Table 1. HP-Adhesins and their association with H. pylori-related disease 
Protein - abbreviation  
 
Function Clinical association Reference(s) 
Blood group antigen-
binding adhesin-BabA 
 
 
Binds on Lewis b (Le
b
) 
ABO blood group antigen 
on the surface of 
epithelial cells 
Correlation babA2 allele 
and development of 
gastric diseases 
Ilver et al., 1998 
Gerhard et al, 1999 
Olfat et al., 2005 
Yamaoka, 2008 
 
 
Sialic acid binding 
adhesin-SabA 
 
Adheres to sialyl-Le
x
 and 
sialyl-Le
a
 antigens and is 
involved in activation of 
neutrophils  
None Mahdavi et al., 2002 
De Jonge et al., 2004 
Unemo et al., 2005  
 
 
Sialic acid binding 
adhesin-SabB  
 
Binding specificity is 
unknown 
A nonfunctional sabB 
gene is a predictor of 
duodenal ulcer disease 
De Jonge et al, 2004 
 
 
 
Outer inflammatory 
protein A-OipA 
 
Associated with 
increased interleukin 
(IL)-8 secretion 
 
Increases gastric 
inflammation in vivo 
Yamaoka et al., 2000 
Helicobacter pylori 
outer-membrane protein 
B-HomB  
 
Associated with 
increased interleukin 
(IL)-8 secretion 
homB status is a putative  
marker for the risk of 
development of gastric 
cancer 
 
Oleastro et al., 2008  
Jung et al., 2009 
 
H. pylori adhesin A-
HpaA 
 
Results of adhesion 
studies are not conclusive 
Unknown O‟Toole et al., 1995 
Jones et al., 1997 
Carlsohn et al., 2006 
 
AlpA and AlpB 
 
Inactivation of the 
respective genes results 
in decreased adherence to 
gastric epithelial cells in 
a guinea pig model 
 
Unknown Odenbreit et al., 1999  
De Jonge et al., 2004 
 
HorB Disruption of the horB 
gene reduces H. pylori 
adhesion to gastric 
Unknown Snelling et al., 2007 
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epithelial cells by more 
than twofold. 
 
HP-NAP This neutrophil-activating 
protein is reported to be a 
possible adhesin to mucin 
Unknown Evans et al., 1995 
Namavar et al., 1998 
Tonello et al., 1999  
Montemurro et al., 2001 
Montemurro et al., 2002 
 
Duodenal ulcer 
promoting gene-DupA 
The dupA gene encodes 
for a VirB4 ATPase 
homolog. There are two 
alleles: dupA1 and dupA2 
Associated with gastric 
and duodenal ulcers. The 
association with gastric 
cancer is not universal. 
 
Lu et al., 2005 
Hussein, 2010a 
Hussein et al., 2010b 
“Induced by contact with 
epithelium” coding gene-
IceA 
The iceA1 allele encodes 
a CATG-recognizing 
restriction endonuclease. 
Association with peptic 
ulcers is not universal. 
Peek et al., 1998 
Yamaoka et al., 1999 
Donahue et al., 2000 
Kidd et al., 2001 
Xu et al., 2002 
 
2.2.Virulence factors involved in the induction of gastric lesions  
Urease is not only essential in the H. pylori acid resistance (2.1.), the urease-mediated 
production of ammonia has also been shown to reduce the viability of gastric epithelial cells 
(Smoot et al., 1990). Ammonia or urease molecules are probably unable to directly induce 
apoptosis, but ammonia would accelerate cytokine-induced apoptosis in gastric epithelial cells 
(Igarashi et al., 2001). After damaging the mucosal barrier, nutrients for the microorganism 
are released, which in turn sustains the inflammation process (Smoot et al., 1990). 
The Cytotoxin-associated gene pathogenicity island or cagPAI, is the most widely 
examined virulence factor of H. pylori (Cover et al., 1990). No homologs have been reported 
in any other Helicobacter species. Approximately 50 to 70% of H. pylori strains represent the 
cagPAI, rendering these strains more virulent (Tummuru et al., 1993; Cover et al., 1995; 
Ching et al., 1996; Akopyants et al., 1998). These so-called cagA
+ 
strains do not only induce 
significant antibody titers after infection, they also induce a higher inflammatory response and 
carry a significantly higher risk for the development of peptic ulcer disease or gastric cancer 
in Western populations, than avirulent strains, lacking the cagPAI (Kuipers et al., 1995; 
General introduction 
18 
 
Blaser and Crabtree, 1996; van Doorn et al., 1999). In Asian populations, this outcome was 
not observed (Peek et al., 1995; Beales et al., 1996; Go and Graham, 1996; Hamlet et al., 
1999). The cagPAI consists of about 30 genes, and encodes a type IV secretion system 
(Akopyants et al., 1998) which mediates the formation of a syringe-like structure, that 
penetrates the epithelial cells in the stomach, delivering the CagA protein and possibly other 
bacterial factors into the host cells (Covacci et al., 1993; Segal et al., 1999; Asahi et al., 2000; 
Christie and Vogel, 2000; Odenbreit et al., 2000; Fischer et al., 2001; Backert et al., 2008). 
Once inside the cytoplasm of the host cell, the CagA protein is phosphorylated at tyrosine 
residues in EPIYA motifs (Segal et al., 1999; Asahi et al., 2000; Odenbreit et al., 2000; Stein 
et al., 2000; Higashi et al., 2002) by Scr family kinases (Figure 3) (Selbach et al., 2002; Stein 
et al., 2002). Phosphorylated CagA then interacts with tyrosine phosphatase SHP-2 (Higashi 
et al., 2002), which results in morphological changes in the epithelial cells, including 
elongation and spreading of the cells, which has been called “hummingbird” phenotype (Segal 
et al., 1999; Yamazaki et al., 2003). CagA also interacts with Grb2, which in turn indirectly 
leads to the activation of pro-inflammatory nuclear factor (NF)-ĸB, cytoskeletal 
rearrangements and proliferation of cells in vitro (Brandt et al., 2005; Mimuro et al., 2007). 
Both overexpression of pro-apoptotic proteins and (to a lesser extent) overexpression of anti-
apoptotic proteins have been described after human infections with cagA
+
 strains (Cabral et al, 
2006). Mimuro et al. (2007) suggested that the anti-apoptotic effects of CagA may aid 
persistence, by maintaining the turnover of the epithelial cells to which H. pylori bacteria are 
attached. 
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Figure 3: The secreted vacuolating cytotoxin, VacA, induces the formation of large vacuoles 
in epithelial cells and mitochondrial-mediated apoptosis. Cytotoxin-associated protein, CagA 
is injected into host cells by a specialized type IV secretion system and causes alterations of 
the cytoskeleton, can induce apoptosis in vitro and signals the nucleus to induce nuclear factor 
(NF)-κB. 
 
Another major virulence factor is the vacuolating cytotoxin (VacA), which is secreted by 
approximately 50% of all H. pylori strains (Cover and Blaser, 1992). VacA induces massive 
vacuolization in epithelial cells (Figure 3), which depends on the formation of membrane 
channels by this very same toxin (Cover and Blaser, 1992; Szabó et al., 1999). There is 
considerable variation in vacuolating activities among strains (Leunk, 1991; Cover and Blaser, 
1992; Cover, 1996; de Bernard et al., 1997). Namely, the toxicity of VacA depends on 
variations of the signal region (s) and the middle region (m) of the encoding gene (Atherton et 
al., 1995; van Doorn et al., 1999). The s region of the gene, occurs as either an s1 or s2 type, 
whereas the m region, exists as an m1 or m2 type (van Doorn et al., 1999). The s1/m1 
genotypes show the highest vacuolating activity and in line with this, these genotypes are 
more frequently associated with peptic ulcers and gastric carcinoma (Atherton et al., 1995). 
Vacuolating activity is intermediate in s1/m2 genotypes and absent in s2/m2 alleles. 
Atherton‟s group recently described an intermediate (i)-allele in vacA that determines the 
vacuolating activity among the s1/m2 strains (Rhead et al., 2007). They observed that s1/m2 
General introduction 
20 
 
strains that have an i1 allele are vacuolating, whereas s1/m2 strains that have an i2 allele are 
nonvacuolating. 
Through the formation of pores in epithelial cell membranes, VacA induces the release 
of the urea, nutrients, cations and anions from host cells (Montecucco and de Bernard, 2003). 
Moreover, VacA is able to enter the cytosol, and accumulate in the mitochondrial inner 
membrane, causing a reduction of the mitochondrial transmembrane potential, thereby 
inducing apoptosis by release of the mitochondrial cytochrome c (Kimura et al., 1999; 
Willhite and Blanke, 2004). Interestingly, secreted VacA seems to be able to penetrate into 
tissues deeper than the epithelium, where it can interact with granulocytes, monocytes and B 
and T cells (Molinari et al., 1998). VacA has been shown to inhibit antigen presentation and T 
cell proliferation, but, unlike CagA, VacA does not seem to induce the apoptosis of T cells 
(Molinari et al., 1998; Wang et al., 2001; Gebert et al., 2003). As to the presence of VacA in 
NHPH-species, a vacA homolog has not been detected in H. suis strain 5, but the presence of 
a paralog could be confirmed for H. suis strain 1 (Vermoote et al., 2011). Up till now, the 
presence of VacA in other gastric non-Helicobacter pylori species could not be demonstrated. 
It has been suggested that the cagPAI and vacA genes are able to reduce each other‟s 
effects on epithelial cells, which could lead to avoiding excessive cellular damage (Argent et 
al., 2008). Two complementary mechanisms, in which CagA inhibits VacA-induced apoptosis, 
were identified (Oldani et al., 2009). One depends on the prevention of pinocytosis of VacA 
by tyrosine-phosphorylated CagA, the other one on blocking of VacA-induced apoptosis at 
the mitochondrial level, which doesn‟t require phosphorylation of CagA. 
γ- glutamyl transpeptidase (GGT) activity is found in all gastric Helicobacter 
species including H. suis, and has a conserved function in the genus Helicobacter 
(Haesebrouck et al., 2009; Wachino et al., 2010; Rossi et al., 2012). The role of GGT as a 
virulence factor of gastric Helicobacter species, however, has only been investigated for H. 
pylori and, more recently, for H. suis as well. Membrane-associated H. pylori GGT activity 
plays an important role in the metabolism of glutathione (Orlowski and Meister, 1970), a free 
thiol maintaining an optimal intracellular redox environment (Circu and Aw, 2010). Moreover, 
H. pylori GGT is very efficient in using both glutamine and glutathione from epithelial cells 
as a source of glutamate (Shibayama et al., 2003). As glutamine and glutathione are important 
nutrients for maintenance of healthy gastrointestinal tissue, their depletion by the GGT 
enzyme probably accounts for the damage of gastric epithelial cells (Shibayama et al., 2007). 
Other studies demonstrated that the H. pylori GGT induces apoptosis of AGS cells via a 
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mitochondrial-mediated pathway and inhibits growth of these cells by inducing cell cycle 
arrest in the GI-S transition phase (Kim et al., 2007; 2010). 
H. pylori GGT has also been shown to play a pivotal role in the inhibition of T-cell 
proliferation and in the upregulation of COX-2 and EGF-related peptide expression, 
suggesting a possible role in gastric carcinogenesis (Busiello et al., 2004; Schmees et al., 
2007). Significantly higher GGT activity has been observed in H. pylori isolates obtained 
from patients with gastric ulcer disease than isolates from patients with non-ulcer dyspepsia 
(Gong et al., 2010).  
Whole-genome screening of H. suis strain 5 has revealed the presence of a gene 
homologous to the H. pylori GGT (Vermoote et al., 2011). Further research showed that the 
enzyme catalyses the degradation of extracellular glutathione (Flahou et al., 2011). The 
degradation products, in turn, cause a cell-independent extracellular generation of H2O2, 
leading to lipid peroxidation and finally, necrosis. During this process, cellular contents, 
including inflammation-promoting molecules, are released from the gastric epithelial cells 
(Fink and Cookson, 2005; Vanlangenakker et al., 2008; Flahou et al., 2010; 2011).  
Neutrophil-activating protein (HP-NAP), another H. pylori factor with pro-
inflammatory capacities, was originally designated to stimulate the production of toxic 
reactive oxygen species (ROS) in neutrophils and promote adhesion of neutrophils to 
endothelial cells (Evans et al., 1995). HP-NAP was found to be chemotactic for human 
neutrophils and monocytes in vitro and to promote rapid neutrophil adhesion in vivo in rats 
(Satin et al., 2000; Polenghi et al., 2007). Furthermore, after crossing the epithelial monolayer, 
HP-NAP is able to activate underlying mast cells, monocytes and neutrophils, which in turn 
release pro-inflammatory cytokines (Montemurro et al., 2001; 2002; Amedei et al., 2006; 
Polenghi et al., 2007). A recent study showed that in vitro exposure of monocytes to HP-NAP, 
induced anti-apoptotic proteins, and reported that HP-NAP promotes survival of neutrophils 
in a monocyte-dependent manner (Cappon et al., 2010). As a result, the lifespan of monocytes 
and neutrophils is increased, which further contributes to inflammation. 
HP-NAP induces the expression of IL-12 and IL-23 by human neutrophils and 
monocytes, and has the potential to shift antigen-specific T cell responses from a predominant 
T helper (Th)2 to a Th1 cytotoxic phenotype (Amedei et al., 2006; D‟Elios et al., 2007). As a 
result, high levels of interferon (IFN)-γ and tumor necrosis factor (TNF)-α are produced. 
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Homologs of the napA gene, have been found in the genomes of H. suis, H. felis, H. 
bizzozeronii, H. heilmannii and H. mustelae (O‟Toole et al., 2010; Arnold et al., 2011; Schott 
et al., 2011; Vermoote et al., 2011; Smet et al., 2013). 
Table 2. H. pylori virulence-associated genes for which homologues were detected in the 
genomes of H. heilmannii, H. suis, H. felis and H. bizzozeronii. The proteins they encode 
and the associated function are also presented. References: Arnold et al., 2011; Schott et 
al. 2011; Vermoote et al., 2011; Smet et al., 2013. 
 
H. pylori virulence-
associated genes 
 
Protein Associated function 
urease gene cluster 
ureABIEFGH 
Urease subunit alfa 
Urease subunit beta  
Urease transporter  
Urease accessory proteins 
 
pH homeostasis  
  
tlpA, tlpB 
 
Methyl-accepting 
chemotaxis proteins tlpA, 
tlpB 
Chemotaxis  
horB, hop, hof, hom 
 
Outer membrane proteins  
 
Adhesion 
 
 
   
ggt γ-glutamyl transpeptidase Induction of gastric lesions 
 napA Neutrophil-activating 
protein A 
 
3. Recent developments in the diagnosis of gastric Helicobacter infections 
At present, various tests for the diagnosis of H. pylori infections are readily available, and 
from these, tests were derived for the detection of other gastric Helicobacter species. These 
diagnostic methods include both non- or less-invasive and invasive procedures, which often 
need to be combined in order to ascertain a correct diagnosis. It should be stressed that the 
diagnosis of Helicobacter infections is often hampered by the focal distribution of the bacteria 
in the stomach and the very fastidious nature of the gastric Helicobacter species, with the 
NHPH-species in particular.  
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3.1. Non- or Less-invasive tests 
The 
13
C-urea breath test (
13
C-UBT) is considered to be a simple and safe non-invasive test, 
which is based on the marked urease activity present in all gastric Helicobacter species. 
Orally administrated 
13
C-labelled urea is broken down in the stomach by urease into ammonia 
and soluble 
13
CO2. The latter is absorbed across the mucus layer to the gastric mucosa and 
hence, via the systemic circulation, expired in the exhaled breath. The amount of 
13
C can then 
be measured as a ratio of 
13
C to 
12C in the patient‟s breath, or, in an adapted tool, in the serum 
(Logan, 1998; Graham and Klein, 2000; Gisbert and Pajares, 2004). The 
13
C-UBT protocol 
may be performed with relatively low doses (<100 mg) of urea, with the most common dose 
of urea at 75 mg. After breath collection, as early as 10-15 minutes after urea ingestion, 
analysis can be performed by nondispersive, isotope-selective infrared spectroscopy, laser-
assisted ratio or isotope ratio mass spectrometry (IRMS). Since 
13
C-UBT combines a high 
sensitivity (88%-95%) and specifity (95%-100%) in H. pylori-infected adults, the test is used 
for both initial diagnosis and for the confirmation of eradication after treatment (Malfertheiner 
et al., 2012). In young children, however, a heterogenous accuracy was reported, with 
sensitivity and specificity levels between 75% and 100% before and after treatment of a H. 
pylori infection (Guarner et al., 2010). 
13
C-UBT perfomance variability in children might be 
due to (1) variation in urease activity from oral bacteria; (2) differences in the time at which 
the samples were obtained (eg. a remarkable decrease in specificity is found if samples are 
obtained at 15 minutes instead of 30 minutes); (3) variable cut-off values in different studies; 
(4) the tracer dose (for which a body weight adjustment has been suggested by some authors); 
and (5) pretest meal (Mégraud, 2005; Bik et al., 2006; Vaira et al., 2009, Leal et al., 2011). 
Since accurate, non-invasive tests for the diagnosis of H. pylori infections in younger children 
are highly preferred, several modifications of the protocol have been investigated. However, 
at present, performance criteria have not yet been sufficiently established (Machado et al., 
2004). Likewise, the administration of 
13
C-urea capsules, which was proved effective in adults, 
cannot bring the desired solution, since this is not feasible in infants or toddlers (Vaira et al., 
2009).  
Assumptions should be taken with care, when 
13
C-UBT is carried out immediately 
after emergency endoscopy in peptic ulcer bleeding, since a relatively low sensitivity and 
specificity has been reported in these cases (Barkun et al., 2010; Velayos et al., 2012). 
Another specific group of patients, in which the identification of H. pylori infection is of great 
importance, are patients that have been subjected to a partial gastrectomy. In contrast with 
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what one could expect after partial surgical removal of the stomach, a positive and negative 
predictive value of 0.64 and 0.92 respectively, were observed for UBT (Wardi et al., 2012).  
To the author‟s knowledge, no information is yet available about the sensitivity and 
specificity levels of the application of 
13
C-UBT in patients infected with gastric NHPH. Since 
a more focal distribution of these microorganisms has been described in the human stomach, 
accuracy of 
13
C-UBT might be less than is the case for H. pylori-infected patients 
(Haesebrouck et al., 2009). 
UBT has been applied experimentally in cats and dogs too, in order to detect gastric 
infection with Helicobacter spp. (Cornetta et al., 1998). Next to a difficult usage in animals, a 
lower sensitivity was noted for 
13
C-UBT in comparison with cytological evaluation of 
impression smears or histological examination of biopsy specimens. The result of the test in 
dogs is not only influenced by the speed of gastric emptying and any recent antimicriobal 
therapy, but depends on the colonization level of Helicobacter spp. in the stomach as well 
(Cornetta et al., 1998). False negative results may therefore be obtained when there is only a 
low amount of helicobacters present in the gastric mucosa, while false positive results have 
been described when other urease positive bacteria are present. A more recent study, however, 
reported a sensitivity and specificity of 89% for 
13
C-UBT in dogs (Kubota et al., 2013). 
Another non-invasive test developed for the detection of H. pylori antigens is the stool 
antigen test (SAT). This test forms a fast, safe, and reliable tool for the detection of H. pylori 
antigens in human fecal samples (Gisbert and Pajares, 2004). For this diagnostic method, 
which is usually recommended in children when 
13
C-UBT is not possible, no expensive 
equipment and medical personnel is needed (Cirak et al., 2007; Choi et al., 2011; Chehter et 
al., 2013). Two types of stool antigen tests are available: the enzyme immunoassay or EIA 
and an assay based on immunochromatography (ICA). In the EIA test (eg. The Testmate 
pylori antigen EIA), a drop of the suspended stool sample is mixed with a peroxidase-
conjugated H. pylori antibody and, after incubation and washing steps, the optical density is 
measured (Suzuki et al., 2002). Early EIAs were based on polyclonal antibodies, and although 
they provided reliable results for the diagnosis of H. pylori infection, controversial results 
were sometimes observed in the post-eradication assessment (Odaka et al., 2002; Veijola et al., 
2005). The more recently developed monoclonal antibody-based techniques generally have a 
higher specificity (Domínguez et al., 2006; Deguchi et al., 2009). Tests based on 
immunochromatography (ICA) are often presented as a strip (eg. Testmate rapid pylori 
antigen) to which a drop of suspended stool sample is applied (Suzuki et al., 2002). When H. 
General introduction 
25 
 
pylori antigens are present in the stool sample, they form immune complexes with the color-
labeled monoclonal antibodies in the strip, which then migrate by capillary action. Next, these 
immune complexes are captured by secondary antigens and a visible line is formed on the 
strip. Although both types of tests are highly sensitive and specific, a recent study showed that 
currently available ICA-tests provide less reliable results than EIA-tests (Gisbert et al., 2006; 
Sato et al., 2012; Korkmaz et al., 2013). ICA-tests are, on the other hand, more easy to 
perform and can be used for on spot rapid diagnosis, since they don‟t require any specialized 
equipment (Shimoyama et al., 2011).  
Several factors influence the accuracy of SATs. For example, the accuracy is lower 
when the stool samples are unformed, or watery, because H. pylori-specific antigens are 
diluted (Saez et al., 2012). Moreover, the sensitivity of SATs is lower in patients with 
gastrointestinal bleeding. Other factors that can affect the result of SATs are temperature, the 
interval between stool sample collection and measurement and the antigenicity of H. pylori 
strains (Ritchie et al., 2009; Queiroz et al., 2013). 
Monoclonal antibody-based SAT was proved to be a more reliable non-invasive test 
than UBT in children, both in populations with high and low prevalences of H. pylori 
infection (Cardenas et al., 2008; Queiroz et al., 2013). Similarly, the accuracy of SAT was 
higher than UBT in patients who underwent distal gastrectomy, with a specificity of 90.5%, 
while that of UBT was only 59.1% (Adamopoulos et al., 2009; Yan et al., 2010). 
Stool antigen tests, developed for the use in human medicine, are also useful to detect 
H. pylori in infected animal models, such as C57BL/6 mice (Moon et al., 2013). However, 
antigen assays for application in animal patients have not been developed yet.  
Shinozaki et al. (2002) investigated whether Helicobacter infections in animals could 
be detected by using stool samples in a PCR, based on relatively conserved regions of the 
16S rRNA gene. Sequences derived from fecal material were shown to reflect intestinal 
Helicobacter species, and hold no information on the infection status of the stomach. 
Moreover, the presence of numerous bacterial species, food degradation products and PCR 
inhibiting factors may hamper the PCR, rendering false negative results. In conclusion, stool 
specimens have been shown valuable for the detection of H. pylori infection in humans, but 
are so far not representative for the diagnosis of Helicobacter infections in animals. To date, 
no information is available about the value of stool-antigen tests in the detection of other 
gastric Helicobacter infections in humans. 
General introduction 
26 
 
Serology was one of the first diagnostic methods to be developed after the successful 
cultivation of H. pylori (Jones et al., 1984; Kaldor et al., 1985). Various antigen preparations 
have been examined, eg. preparations from whole cells, sonicated cell extracts, non-ionic 
detergent extracts, highly purified individual antigens and recombinant antigens (Herbrink 
and van Doorn, 2000). The highest sensitivity was shown for the use of complex antigen 
mixtures of various strains. Most commercial tests are based on IgG detection through 
enzyme immunoassay (EIA). Additionally, IgA antibody presence can be tested as well, only 
in some cases rendering a slight increase in sensitivity. One of the limitations of serology, is 
the failure to distinguish between past and present H. pylori infections, even after a successful 
eradiction therapy (Hirschl and Rotter, 1996; Choi et al., 2011). Moreover, individual genetic 
differences have been shown to contribute substantially to the formation of H. pylori 
antibodies. The success of a serological test also depends on the use of antigens that are 
present in H. pylori strains in a given population, since considerable heterogeneity of H. 
pylori strains has been described for different geographical areas (Vale et al., 2008; 2009; 
Vitoriano et al., 2011). Therefore, a local validation of serological tests has been considered 
essential (Malfertheiner et al., 2007). The use of high-molecular-weight, well conserved 
antigens should overcome this limitation as well (Marchildon et al., 2003). 
In a recent study, the performance of 29 different serological test kits was investigated, 
demonstrating sensitivities ranging from 55.6% to 100% and specificities ranging from 59.6% 
to 97.9% (Burucoa et al., 2013). Based on these figures, both the urea breath test (UBT) and 
the monoclonal stool antigen test are assumed to be superior methods than serology for the 
detection of acute H. pylori infections and for therapeutic follow-up (Herbrink and van Doorn, 
2000; Malfertheiner et al., 2007). There are, however, several indications for which serology 
is believed to be the method of choice. Serology is not only recommended for initial screening, 
in which case further confirmation by histology and/or culture is necessary, but is also highly 
relevant in patients receiving antimicrobial treatment or presenting acute bleeding (Rubicz et 
al., 2011; Mégraud, 2012). Serologic tests have also been appreciated in the evaluation of the 
association between H. pylori and gastric carcinoma or extraintestinal diseases, and in the 
context of epidemiologic use and vaccination studies.  
At present, no test for the identification of NHPH-antigens in blood samples of humans or 
animals are available. Obviously, there is a need for a simple and reliable tool to achieve 
diagnosis with identification up to the species level. 
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Several studies investigated the presence of H. pylori in human dental plaque and 
saliva by conducting PCR, culture, determining urease activity, and quantifying specific oral 
antibodies (Marshall et al., 1999; Bode et al., 2002; Cellini et al., 2010). Studies performed 
with saliva of adult patients show an overall sensitivity of 81 to 94% and a specificity of 70 to 
90% compared with endoscopy-based methods (Luzza et al., 1997; De Pascalis et al., 1999; 
Sunnerstam et al., 1999; Malaty et al., 2000). Bode and co-workers evaluated saliva IgG 
against H. pylori in children (Bode et al., 2002). Results were compared in parallel with 
13
C-
UBT results, leading to a sensitivity and specificity of the salivary antibody ELISA of 80.9% 
and 95.3% respectively. These findings add strength to the assumption that salivary ELISA is 
a reliable, convenient, and easy-to use tool, which may be highly valuable in the design of 
diagnostic and epidemiological studies. However, the test should be further evaluated in 
young children, in whom immune responses might not be fully developed (Raymond et al., 
1996).  
Several methods have been assessed in the detection of H. pylori DNA in the oral 
cavity, concluding PCR as the most suitable (Teoman et al., 2007). Using PCR, H. pylori has 
been detected in the mouth of both patients with and without a history of gastric upset 
(Teoman et al., 2007; Souto and Colombo, 2008). Furthermore, the prevalence of H. pylori in 
the oral cavity may be independent of the prevalence of this agent in the stomach after 
successful treatment of infection, indicating the possibility of gastric reinfection through the 
oral cavity as a reservoir (Gebara et al., 2006). 
3.2. Invasive tests 
Endoscopy guided gastric biopsy 
Endoscopic evaluation, in the diagnosis of H. pylori infections, has received increased 
attention as endoscopic imaging can improve early detection of gastric cancer.  
Recently, the diagnostic yield of endoscopy for H. pylori infections was examined (Watanabe 
et al., 2013). Interestingly, intra-observer agreement for H. pylori infection status was good 
for all endoscopists, while inter-observer agreement was lower for physicians at beginning 
level. Evenso, for all physicians, good inter-observer agreement in endoscopic findings was 
shown for atrophic change of the mucosa, but a lower accuracy was found for beginning 
endoscopists.  
Several studies emphasize the high risk of gastric cancer development in patients with 
H. pylori-associated highly-active non-atrophic gastritis. This form of inflammation can be 
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assessed by a combination of (1) serum levels of pepsinogen (PG) I and II, (2) H. pylori 
antibodies and (3) a specific endoscopic feature: endoscopic rugal hyperplastic gastritis (RHG) 
(Watanabe et al., 2012). Rugal hyperplastic gastritis presents large and tortuous gastric folds, 
with a fold width ≥ 5 mm (Oguri et al., 2007). In patients with RHG, high H. pylori antibody 
titers and a low PG I/II ratio, a significantly higher cancer incidence was described. After H. 
pylori eradication, however, no cancer development was observed in these high-risk subjects. 
The optimal biopsy site for H. pylori in patients undergoing endoscopic mucosectomy 
(EMR) has repeatedly been the topic of research (Calvet et al., 2010; El-Zimaity et al., 2013). 
Considering the antrum, corpus lesser curve (CLC), and greater curve (CGC), the authors 
designated the CGC as the optimal biopsy site for H. pylori diagnosis in EMR patients with 
extensive atrophy.  
Attempts have been made to categorize the endoscopic findings characteristic of an H. 
pylori-infected stomach. Diffuse redness, spotted redness, and mucosal swelling have been 
indicated as useful for diagnosing H. pylori-infections (Kato et al., 2013). Most of these 
findings, however, have a rather low sensitivity and specificity, and their presence therefore 
form no reliable diagnostic method. 
In the future, multi-center trials, in which standard and magnifying endoscopy are 
compared, as well as the different levels of experience of the endoscopists, are necessary to 
confirm previously stated data. At this moment, endoscopy is necessarily combined with 
gastroscopic biopsy-based tests, such as the rapid urease test (RUT), histological examination, 
and culture for diagnosis of H. pylori infections. 
Histological examination of gastric biopsies 
Spiral-shaped bacteria, present in patients with active gastritis, were first described by Warren 
through histological examination, and formed the true onset to culture H. pylori (Warren and 
Marshall, 1983). Next to the Warthin-Starry silver stain, used by Warren, numerous other 
stains were found suitable for the detection of H. pylori in gastric biopsy specimens, brush 
cytology and imprint cytology specimens: modified Giemsa, haematoxylin eosine, Gram, 
Genta, toluidine blue, Romanouski and immunohistochemical methods (Warren and Marshall, 
1983; Mendoza et al., 1993; Misra et al., 1993). A recent study confirmed that in most cases, 
immunohistochemical (IHC) stains are not cost-effective or necessary and that HE staining 
remains the most expedient test for the identification of H. pylori (Wang et al. 2010). The use 
of special stains should, therefore, be reserved for biopsy specimens with moderate to severe 
chronic active or inactive gastritis, post-treatment biopsy specimens and for cases in which 
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suspicious structures are observed by HE staining, without leading to a definite diagnosis 
(Aggarwal et al., 2011).  
A major disadvantage, is the contribution of the frequently-used proton pump 
inhibitors (PPIs) in creating false negative diagnosis. Because the number and distribution of 
H. pylori organisms in patients using PPIs is variable, it has been recommended to 
discontinue PPIs two weeks before endoscopy (El-Zimaity et al., 2013). Nevertheless, 
histology is considered as the standard method for the diagnosis of H. pylori infection, 
additionally providing information on the status of the mucosa, eg. the presence of acute or 
chronic inflammation, lymphoid aggregates, intestinal metaplasia, and glandular atrophy 
(Lash and Genta, 2013). The diagnostic reliability of histological examinations largely 
depends on the number and localization of biopsies collected, which is of special importance 
in patients with atrophy (El-Zimaity et al., 2013). As indicated in the previous paragraph, 
specimens obtained from the greater curve (CGC), appear to be best suited for H. pylori 
detection in these patients. Interestingly, the sensitivity of biopsy-based tests seems to 
decrease as the degree of atrophic gastritis increases, regardless the biopsy location (Lan et al., 
2012).  
It should be stressed that histology and cytology are the only routinely available 
methods for the detection of other gastric Helicobacter species in human biopsy-specimens 
(Debongnie et al., 1995). However, microscopic investigation of biopsy samples is not an 
accurate method for species identification, since morphology can slightly alter. In 
fact,electron microscopy (both scanning and transmission), is the only effective tool for the 
differentiation of NHPH species by morphology. Since specific fixation procedures are time-
consuming, and the necessary equipment is expensive, electron microscopy is only 
sporadically applied for identification (Happonen et al., 1998; Stoffel et al., 2000). 
Furthermore, visualization of NHPH-microorganisms is hampered by the focal distribution of 
these bacteria and the morphological differences among these species are not always obvious 
(Happonen et al., 1998). Therefore, identification up to species level, based on in situ 
electronal microscopical images remains very difficult. 
Rapid Urease Test on gastric biopsies 
The rapid urease test (RUT) is based on the urease activity of Helicobacter species, which 
results in the formation of ammonia, as was previously elucidated for the 
13
C-urea breath test 
(3.1.). Many commercial RUTs are available, including gel-based, paper-based and liquid-
based tests. Depending on bacterial load in the biopsy specimen and the format of these tests, 
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they provide a result in 1-24 hours (Tseng et al., 2005). A major advantage of these tests is 
their relative low cost, in comparison with histology and culture (Ozaslan et al., 2010; Choi, 
2012). Overall, commercial RUTs show a high specificity of 95% to 100%; the sensitivity is 
less, ranging from 85% to 95%. In patients with bleeding peptic ulcers or partial gastrectomy, 
however, the sensitivity can decrease down to 67%-85%, and 79% respectively (Tseng et al., 
2005; Gisbert et al., 2006; Choi et al., 2012; Tian et al., 2012). A reduced sensitivity has also 
been reported in case of formalin contamination of the forceps, used for collection of the 
biopsies (Ozaslan et al., 2010; Choi et al., 2012). A higher sensibility of RUT can be obtained 
by increasing the number of biopsy specimens and including various regions from the 
stomach (Hsu et al., 2010). In addition, combining different specimens prior testing, improves 
the detection rate and speed, compared to testing with separate specimens (Moon et al., 2012).  
Measuring the urease activity in a certain time period, might allow a semi-quantitative 
determination of the colonization density (Happonen et al., 1998). False negative results, 
however, are more frequently encountered in the case of low grade colonization, than for 
example with histology or molecular techniques. 
Culture of gastric biopsies 
Culture is being considered the gold standard for H. pylori diagnosis, since it can be 
performed directly from biopsy samples and has a specificity of up to 100% (Ndip et al., 
2003). Although sensitivity was reported > 90%, significant variation have been shown. 
These mainly depend on the quality of the specimens and transportation conditions. Moreover, 
immediate attention is necessary for specimens obtained for culture, since Helicobacter 
organisms are very fastidious and fragile outside their native environment (Ricci et al., 2007).  
Despite the common presence of spiral bacteria in the gastric mucosa of pigs, dogs and 
cats, isolation and cultivation of NHPH form a very laborious process with low success rate 
(Happonen et al., 1998; Jalava et al., 1998). Jalava and co-workers conducted one of the more 
successful isolation procedures, obtaining an isolation rate of up to 51% from canine 
stomachs (Jalava et al., 1998). The majority of the isolated strains were identified as H. 
bizzozeronii (55.6%), while H. felis and H. salomonis were both identified in 22.2% of the 
cases. In cats, however, the isolation rate was only 13.6%, and all isolated strains were 
designated as H. felis.  
Only a few years ago, a successful in vitro isolation method for H.suis was described, 
using a new biphasic culture method (Baele et al., 2008). After genomic fingerprinting of the 
in vitro isolates HS1, HS2, and HS3 by amplified fragment length polymorphism (AFLP), 
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distinct AFLP patterns were revealed for these 3 isolates. Since the description of this 
isolation method, 20 H. suis strains have been isolated from the gastric mucosa of pigs from 
different herds. These in vitro isolates are, to the author‟s knowledge, the only available 
isolates worldwide. Until now, no H. suis isolates, originating from infected humans, have 
been obtained. In fact, only few studies report successful isolation of NHPH species from 
human gastric biopsies. A German study described the first isolation of Helicobacter felis 
from an infected human (Wüppenhorst et al., 2012). The authors succeeded by using their 
routine H. pylori isolation protocol, on gastric biopsy specimens from a 14-year-old girl, 
presenting with persistent epigastric pain and vomiting episodes. The only other NHPH-
species that has been successfully cultivated from gastric biopsy tissues of human patients is 
H. bizzozeronii (Andersen et al., 1999; Kivistö et al., 2010; Schott et al. 2011). 
In conclusion, to date, culture-based methods for routine diagnosis of NHPH-
infections in animals and humans are currently not feasible. 
 
Polymerase chain reaction analysis on gastric biopsies  
Molecular tests are frequently applied in the diagnosis of infections, due to their speed, 
accuracy, and sensitivity. In addition, these tests not only allow diagnosis, but also the 
detection of virulence factors, and in case of quantitative (q)PCR bacterial quantification. 
Moreover, molecular detection of microorganisms is also possible in a number of materials 
obtained by non-invasive methods (eg. stool and saliva specimens) (Fontana et al., 2003; 
Schabereiter-gurtner et al., 2004). PCR, and real-time (RT) PCR in particular, not only show 
good diagnostic reliability, they are also valuable for the detection of clarithromycin 
resistance in H. pylori (Schabereiter-Gurtner et al., 2004). Since clarithromycin forms one of 
the key agents in the treatment of H. pylori infections, questions were raised regarding the 
usefulness of the classical “test and treat” strategy. A culture-independent molecular test, in 
recognition of clarithromycin resistance, would allow the prudent use of this antimicrobial 
drug and would probably dramatically reduce treatment failures. 
PCR-analysis of the VacA gene in gastric biopsies, has shown to be very valuable in 
patients with severe precancerous lesions (intestinal metaplasia type III and dysplasia) (de 
Martel et al., 2010). In this setting, PCR displayed a significantly elevated sensitivity for the 
detection of H. pylori infection in comparison with histopathology. 
Since the recognition of “other” gastric helicobacters, several PCR protocols have 
been developed, mostly based on a part of the 16S rRNA or the urease gene (De Groote et al., 
2001; Norris et al., 1999; Hwang et al., 2002; Baele et al., 2004; O‟Rourke et al., 2004). In a 
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study by Ekman et al (2013), two multiplex PCR reactions with three, species-specific primer 
pairs in each reaction, were assessed on saliva, stomach, duodenum and faeces samples of 
dogs. All dogs harboured more than two different Helicobacter spp. in their gastric mucosa, 
and in two dogs four different species were found. A high prevalence for H. bizzozeronii, and 
H. salomonis was reported in the stomach of clinically healthy dogs, while DNA of these 
species was only occasionally detected in saliva.  
4. Host response to gastric NHPH infections 
In contrast with the scarce information on host immune responses against NHPH, several 
studies evaluated the innate and acquired immune responses against H. pylori. Instead of 
reviewing the available literature on host immune responses against H. pylori, the following 
section is focused on the recent insights on the acquired immune response elicited by H. suis 
and other gastric NHPH species, reflecting on similar or opposite observations made for H. 
pylori. 
One study reported an increased messenger (m)RNA expression of IFN-γ and IL-10 
in the gastric mucosa of H. suis infected mice, indicating both T-helper 1 (Th1) and T-helper 
2 (Th2) responses are associated with infection (Park et al., 2008). Other studies reported an 
upregulation of mRNA expression levels of IFN-γ in the murine gastric mucosa, indicating a 
Th1 response (Nobutani et al., 2010; Mimura et al., 2011; Vermoote et al. 2012; 2013). In a 
more recent study, pure H. suis cultures were used for experimental infection of both BALB/c 
and C57BL/6 mice, which led to a mild up-regulation of the Th2 signature cytokine, IL-4, 
only (Flahou et al., 2012). In comparison, a Th2 response which is associated with a 
suppression of the inflammatory response and with increased H. pylori colonization, has been 
observed in the H. pylori-infected gastric mucosa too (Serrano et al., 2007; Robinson and 
Atherton, 2010). The predominant T cell response to H. pylori in humans, however is formed 
by a CD4
+
 T cell or Th1 response (Fan et al., 1994; D‟Elios et al., 1997; Bamford et al., 1998). 
These Th1 cells are associated with reduced bacterial colonization in the human gastric 
mucosa as well as in mouse models (Holck et al., 2003; Lucas et al., 2001; Stoicov et al., 
2004). For H. pylori, the Th1 cell-mediated responses and cytokines are known to be 
important in the development of infection-induced gastric pathology (Mohammadi et al., 1996; 
Smythies et al., 2000; Sommer et al., 2001). In addition, IFN-γ itself appears to be a key 
mediator in the development of pre-cancerous gastric atrophy, metaplasia and dysplasia. In 
vitro studies have suggested a number of H. pylori virulence factors to promote Th1 responses. 
HP-NAP promotes the expansion of IFN-γ-producing cells, while in contrast, it aids in the 
General introduction 
33 
 
decrease of IL-4-secreting cells, which are part of a Th2 immune-response (Amedei et al., 
2006). Whether the H. suis homolog of HP-NAP inhibits a similar role in the modulation of 
the host response remains to be elucidated.  
Next to a Th1 and Th2 response, Th17 cells have also been identified in the response 
to H. suis and H. pylori infections respectively in mice and humans (Luzza et al., 2000; 
Mizuno et al., 2005; Vermoote et al., 2012; 2013). Th17 cells secrete IL-17 (which is known 
as a pro-inflammatory cytokine) and play a role in the induction of IL-8 secretion and the 
recruitment of neutrophils to the site of infection. Moreover, a Th17 response, associated with 
elevated gastric IL-1β, has been described in patients with past H. pylori infection, suggesting 
that persistent inflammation might contribute to the development of gastric cancer (Serelli-
Lee et al., 2012). Expression of both IL-17 and IL-6 (promoting Th17 response) mRNA are 
negatively correlated with H. suis colonization in mice (Flahou et al., 2012). Although some 
authors suggest the opposite, most researchers agree there is a similar, negative correlation 
between a Th17 response and H. suis or H. pylori colonization levels (Scott Algood et al., 
2009; Kao et al., 2010; Shi et al., 2010; Vermoote et al., 2011; 2012).  
Moreover, a significant correlation between the reduction of H. suis colonization 
levels and decreased expression levels of IL-10 was observed during vaccination studies in 
mice (Vermoote et al., 2011; 2012). IL-10, an anti-inflammatory cytokine is produced by 
regulatory T cells or Tregs (Roncarolo et al., 2006). Tregs are mainly CD4+ cells, that have a 
key role in the prevention of unwanted immune-mediated responses, such as allergies and 
autoimmunity diseases and are currently considered as a major obstacle in Helicobacter 
vaccination studies (Coombes et al., 2005; Hawrylowicz and O‟Garra, 2005; Roncarolo et al., 
2006). Kao and co-workers showed that, after in vitro exposition to H. pylori antigens, 
dendritic cells turned from a Th17/Th1 response toward Treg differentiation, thereby 
hampering an effective cell-mediated immune response against H. pylori, and probably H. 
suis infections too (Kao et al., 2010).  
As the B-cell response is believed to play an important role in the pathogenesis, 
Vermoote et al. (2011; 2012) observed a significant correlation between the reduction of 
gastric H. suis colonization and an increase of antigen-specific antibodies in vaccinated mice. 
These findings correspond with some H. pylori vaccination studies, whereas others described 
a successful immunization of B-cell deficient mice, indicating that antibodies are not essential 
for protection (Czinn et al., 1993; Ermak et al., 1998; Blanchard et al., 1999; Goto et al., 1999; 
Sutton et al., 2007; Garhart et al., 2003a; 2003b; D‟Elios et al., 2007; Jeremy et al., 2006; 
Morihara et al., 2007). Indeed, the effect of antibodies on the bacterial colonization remains 
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controversial. Intragastric administration of H. felis monoclonal IgA was shown to mediate 
protection against infection in mice in one report (Czinn et al., 1993). In other reports, specific 
IgA and IgG was shown to promote bacterial colonization (Akhiani et al., 2004; 2005). 
Overall, future research should elucidate which role humoral and/or local antibodies play in 
the host response to NHPH-infections. 
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Helicobacter (H.) suis is the most prevalent non-Helicobacter pylori Helicobacter (NHPH) 
species in humans suffering from gastric disorders. H. suis gastritis more frequently leads to 
mucosa-associated lymphoid tissue (MALT) lymphoma than gastritis associated with H. 
pylori infections, which further emphasizes its clinical relevance. The exact source of H. suis 
infections for humans is still not known. However, contact with pigs or pork products 
represents a plausible mode of transmission. Demonstrating H. suis infections in humans with 
gastric disease is far from being simple. Among other things, it is hampered by the very 
fastidious nature of this bacterium and its focal distribution in the stomach. Detecting anti – H. 
suis antibodies could offer a valuable alternative.  
The general aims of the present thesis were to identify potential sources of infection with H. 
suis for humans and to investigate the possibility of improving the diagnostic methods used in 
human clinical practice. The specific aims are given below. 
The first specific aim (Chapter 1) was to determine whether H. suis bacteria can persist in 
pork. As H. suis is extremely difficult to isolate, the development of a non-culture based 
method to quantify viable H. suis bacteria was needed. Such method will enable to study H. 
suis occurrence in pork and to determine if H. suis is still present at retail.  
Subsequently, the aim of the second study was to examine H. suis occurrence on pork 
carcasses at slaughter, elucidating their potential importance in the food chain (Chapter 2). 
In contrast with the well-established diagnostic tests for H. pylori infections, the diagnosis of 
H. suis (and by extension all other gastric NHPH) infections in humans, poses a challenge. 
Helicobacter suis specific serology could provide a simple, reliable diagnostic method. The 
third specific aim of this thesis (Chapter 3) was to identify H. suis-specific protein antigens 
which elicit an immune response in infected humans and could therefore be of value as target 
in future serological test methods. 
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Abstract 
Helicobacter (H.) suis colonizes the gastric mucosa of pigs world-wide and is the most 
prevalent non-Helicobacter pylori Helicobacter species in humans. This agent might be 
transmitted to humans by manipulation or consumption of contaminated pork. H. suis is a 
very fastidious micro-organism and is extremely difficult to isolate. Therefore, we developed 
a non-culture dependent, quantitative detection method allowing differentiation of viable from 
dead H. suis bacteria in pork. This was established by a combination of ethidium bromide 
monoazide (EMA) treatment and real-time (RT)-PCR. This EMA RT-PCR was applied to 50 
retail pork samples. In two samples, viable H. suis bacteria were detected. Sequence analysis 
of the obtained PCR products confirmed the presence of H. suis DNA. Viable H. suis bacteria 
persisted for at least 48 h in experimentally contaminated pork. In conclusion, consumption of 
contaminated pork may constitute a new route of transmission for H. suis infections in 
humans. 
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1. Introduction 
Gastric diseases in humans, such as gastritis, peptic ulcer disease, gastric adenocarcinoma and 
mucosa-associated lymphoid tissue (MALT) lymphoma, have been commonly associated 
with Helicobacter (H.) pylori infections (Kusters et al., 2006, Marshall and Warren, 1984, 
Parsonnet et al., 1991a, Parsonnet et al., 1991b, Parsonnet et al., 1994 and Parsonnet, 1994). 
H. pylori, however, is not the only Helicobacter species capable of colonizing the human 
gastric mucosa. Spiral-shaped non-H. pylori helicobacters (NHPH) have been demonstrated in 
0.1–6.2% of all human gastric biopsies (Baele et al., 2009, Coman et al., 1996, Heilmann and 
Borchard, 1991, Ierardi et al., 2001, Mention et al., 1999, Stolte et al., 1994, Stolte et al., 
1997 and Yali et al., 1998). The pig-associated bacterium H. suis comprises 13.9% to 78.5% 
of human NHPH infections, which makes this species the most prevalent gastric NHPH in 
humans (De Groote et al., 2005, Haesebrouck et al., 2009, Trebesius et al., 2001 and Van den 
Bulck et al., 2005). In a recent study, results of multilocus sequence typing revealed that 
human-and pig-derived H. suis strains are closely related, indicating that H. suis infections in 
humans indeed originate from pigs (Liang et al., 2013). It has been suggested that H. suis 
bacteria might be transmitted to humans by consumption of contaminated pork (Van den 
Bulck et al., 2005). However, nothing is known concerning the presence and persistence of H. 
suis bacteria in pork. Isolation and cultivation of H. suis is a very laborious process with a low 
success rate, rendering detection of live H. suis bacteria in food by using culture-based 
methods not feasible. Using ethidium monoazide (EMA) in combination with real time (RT)-
PCR, detection and differentiation of viable vs. dead bacteria in mixed cell populations has 
been established in several other bacterial taxa (Cawthorn and Witthuhn, 2008, Nocker and 
Camper, 2006, Nogva et al., 2003 and Rudi et al., 2005). EMA, a fluorescent dye, penetrates 
compromised cytoplasmic membranes of dead cells and subsequently intercalates into the 
double helical DNA (Nogva et al., 2003, Rudi et al., 2005, Hixon et al., 1975a and Hixon et 
al., 1975b). Subsequent photoinduced cross-linking inhibits PCR amplification of DNA from 
dead cells. 
The aim of this study was to determine whether pig meat constitutes a possible source 
of H. suis infections for humans. Therefore, a protocol for pork sample treatment with 
ethidium monoazide (EMA) in combination with (RT-)PCR was developed for the selective 
detection of viable H. suis bacteria. Using this technique, the persistence of H. suis bacteria in 
pig meat was evaluated and the occurrence in pork at retail was assessed. 
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2. Materials and methods 
2.1. Bacterial strains and culture conditions 
H. suis strain HS5, which was isolated from the gastric mucosa of a sow according to the 
method described by Baele et al. (2008), was used in this study. The bacteria were grown on 
Brucella culture plates (Oxoid, Basingstoke, UK) supplemented with 20% heat inactivated 
fetal calf serum (HyClone, Logan, UT, USA) and Vitox and Skirrow supplements (Oxoid) 
topped with Brucella Broth (Oxoid). Both agar and broth pH were adjusted to 5 by adding 
HCl. Growth was established in a microaerobic atmosphere (85% N2, 10% CO2, 5% O2) at 
37 °C. 
2.2. Preparation of viable and dead H. suis suspensions 
After 72 h of incubation, H. suis bacteria were harvested from the liquid phase of the biphasic 
medium and the concentration of viable bacteria per ml was counted with a Neubauer 
counting chamber. Tenfold dilution series (10
8
 to 1 ml
− 1
) of live H. suis bacteria were 
prepared in duplicate (series 1 and 2). All dilutions of series 1 were heated for 10 min at 
100 °C. Series 2 included viable H. suis bacteria. Viability after heat-treatment was evaluated 
by examining the motility of the bacteria by light-microscopy and by cell viability assessment 
using the LIVE/DEAD® BacLight™ Viability Kit (Invitrogen, Carlsbad, CA, USA). 
2.3. EMA treatment of viable and heat-killed H. suis bacteria 
Ethidium monoazide (EMA) (Sigma, St. Louis, MO, USA) was dissolved in 4 ml 
dimethylformamide (DMF) and 1 ml RPMI-1640 Medium (Sigma) to obtain a stock 
concentration of 1 mg ml
− 1
. In different repeats, all dilutions of both series 1 and 2 were 
treated with final concentrations of either 10 or 20 μg ml− 1 EMA in 24 well cell culture 
plates. The samples were covered in aluminum foil and placed on a shaker (600 RPM) at 
room temperature for 10 min. Thereafter, all samples were placed on ice and irradiated for 2, 
5 or 10 min with a 500 W halogen light source, which was placed at a distance of 25 cm. This 
protocol was then repeated, adding the same concentration of EMA to the samples, and 
applying the same period of incubation and irradiation. Next, all suspensions were transferred 
to Eppendorf tubes, pelleted by centrifugation at 5000 ×g, and washed twice to remove 
unbound EMA. Final pellets obtained by 5 min centrifugation at 5000 ×g were resuspended in 
250 μl Hanks' Balanced Salt Solution (HBSS–GIBCO®, Invitrogen). 
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2.4. DNA isolation and quantification 
DNA extraction of bacterial suspensions was done by using PrepMan Ultra (Invitrogen), 
according to the manufacturer's protocol. For optimization of the EMA staining technique, 
conventional PCR (40 cycles; annealing temperature at 60 °C) was performed using the 
following primers: UreSu 531 FW (5′-CAC CAC CCC GGG GAA GTG ATC TTG-3′) and 
UreSu 783 RV (5′-CTA CAT CAA TCA AAT GCA CGG TTT TTT CTT CG-3′), resulting 
in a 253-bp PCR product of the ureA gene of H. suis, as visualized using 1.5% agarose gel 
electrophoresis. For subsequent experiments the same primer set was used for quantitative 
RT-PCR. RT-PCR was performed on each sample of both series, to determine the number of 
H. suis bacteria ml
− 1
. An external standard, comprising tenfold dilutions of a 1541 bp ureA–
ureB gene segments, was used starting at 10
10
 amplicons for each 10 μl of reaction mixture 
(primers: forward 5′-GGTGTTGCCCATATGATTCA-3′; reverse 5′-
CGAATCCTAGAGTCAGCAA-3′). The amplicons were purified with Invisorb® Fragment 
Cleanup (according to the manufacturer's instructions; Invitek, Berlin, Germany). The copy 
number concentration was calculated based on the expected length of the amplicon and its 
dsDNA amount. The RT-PCR-mix, with a total volume of 10 μl per well, consisted of 5 pmol 
of UreSu 531 FW and UreSu 783 RV primers, 5 μl of iQ™ SYBR® Green Supermix (Bio-
Rad, Hercules, CA, USA) and 1 μl extracted DNA. RT-PCR was performed on a CFX96 RT 
PCR System with a C1000 Thermo Cycler (Bio-Rad). The cycling conditions were an initial 
cycle at 95 °C for 15 min, followed by 40 cycles at 95 °C for 20 s and 60 °C for 30 s. Both 
standard and samples were run in duplicate. 
2.5. Application of EMA RT-PCR to detect viable H. suis bacteria in artificially 
contaminated pork 
To determine the usefulness of the EMA RT-PCR technique in detecting live H. suis bacteria 
in pig meat, minced pork was spiked with a known number of either live or dead H. suis 
bacteria. Therefore tenfold dilution series (10
8
 to 1 ml
− 1
) containing live or dead H. suis 
bacteria were prepared as described before. For 25 g of minced pork, 250 μl of each dilution 
was added, as well as 5 ml Hank's Balanced Salt Solution (HBSS–GIBCO®, Invitrogen). 
Minced pork with HBSS was included as a negative control. Next, each spiked pork sample 
was homogenized in a stomacher for 2 min by using stomacher bags with a built-in filter 
membrane and with a pore size of 70 μm (BagPage®, Interscience, St Nom la Bretêche, 
France). All stomacher bags were sealed and incubated at 4 °C. Each pork mixture was 
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homogenized again as described before, after 0, 24 or 48 h of incubation. Subsequently, 
250 μl of the obtained filtered suspensions were treated with EMA twice as described above. 
In addition, in a second group of spiked pork samples, 250 μl of each suspension was 
centrifuged for 5 min at 5000 ×g, without prior EMA-treatment. All pellets were washed 
twice in 1 ml HBSS. After a final centrifugation at 5000 ×g for 5 min, the pellets were treated 
with PrepMan Ultra (Invitrogen) according to the manufacturer's protocol, whereupon they 
were subjected to the same RT-PCR as described before. 
2.6. Detection of viable H. suis in commercial pork samples 
Fifty vacuum wrapped minced pork samples, purchased at 4 different local supermarkets over 
a period of 14 weeks, were submitted to the double EMA RT-PCR technique as described 
above. Positive PCR products were subjected to sequence analysis of the ureA gene to 
confirm the identification of H. suis bacteria. 
3. Results 
3.1. Optimization of EMA-PCR for detection of viable H. suis bacteria 
Death of 100% of the H. suis bacteria by heat-treatment for 10 min at 100 °C could be 
confirmed, both by microscopic examination of motility of the bacteria and by live/dead 
staining. 
Single EMA-treatment of H. suis bacteria was unsuccessful for sound differentiation 
of viable from dead bacteria (data not shown). When EMA concentrations of 50 μM or higher 
were used, this resulted in unspecific inhibition of DNA amplification. Using lower 
concentrations of EMA, however, resulted in an incomplete suppression of PCR products 
generated from dead cells. By repeating the EMA treatment before PCR-amplification, only 
samples containing viable H. suis bacteria showed a band on an agarose electrophoresis gel. 
DNA from heat-killed H. suis bacteria was not amplified. These results were obtained for 
both EMA concentrations (10 μg ml− 1 and 20 μg ml− 1) with an irradiation time of 5 min and 
are shown in Fig. 1. A light exposure time of 2 min, on the other hand, resulted in an 
inhibition of amplification of the DNA from the viable bacteria. An irradiation time of 10 min 
also resulted in insufficient distinction between viable and dead bacteria. Probably, live 
bacteria were killed by heat during this procedure. Taken together, the double treatment with 
EMA at a concentration of 10 μg ml− 1 or 20 μg ml− 1 gave equivalent results, when an 
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irradiation time of 5 min was used. For further studies, we used the double EMA protocol at 
10 μg ml− 1. 
 
Figure 1. Electrophoresis gel of PCR products after double-EMA treatment of serial dilutions 
of H. suis bacteria. The upper lane shows concentrations of either live (L) or dead (D) H. suis 
bacteria ml
− 1
. The lower lane represents the EMA concentration (μg ml− 1). 
 
3.2. Validation of EMA RT-PCR on spiked pork samples and survival of H. suis bacteria 
in pork 
The correlations between EMA RT-PCR results and the number of viable or dead bacteria 
added per gram pork are shown in Fig. 2, and demonstrate that the developed EMA RT-PCR 
detects as few as 10 viable bacteria added per gram of minced pork. 
 
 
Figure 2. Scatter plot showing a linear trend between the number of H. suis bacteria added 
per gram of pig meat and the number detected per gram immediately after experimental 
contamination (shown as black diamonds). The gray cubes show viable H. suis bacteria 
present (4 and 21 per gram) in two retail pork samples. 
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By treating dead H. suis bacteria twice with EMA, no DNA amplification was established. 
After 24 and 48 h of incubation at 4 °C, viable H. suis bacteria could still be detected in 
samples with initial concentrations ranging from 10 to 10
6
 viable H. suis bacteria added per 
gram (Fig. 3). 
 
Figure 3. Survival of H. suis bacteria in pork was determined by performing EMA RT-PCR 
24 h (shown as black diamonds) and 48 h (shown as gray cubes) after contamination. H. suis 
DNA could not be detected in control groups containing up to 10
6
 heat-killed bacteria g
− 1
 pig 
meat. 
3.3. Occurrence of viable H. suis bacteria in minced pork at retail 
In two out of 50 retail pork samples, DNA from live H. suis bacteria was detected with the 
EMA RT-PCR method, with the presence of 4 and 21 viable bacteria per gram of pork 
respectively ( Fig. 2). When performing RT-PCR without prior EMA-staining on the two 
positive pork samples, 4 and 49 bacteria per gram were detected respectively. In none of the 
other 48 retail pork samples H. suis DNA was detected. Sequence analysis of the positive 
PCR products confirmed the presence of H. suis DNA with 100% identity to the ureA gene of 
several known H. suis strains (GenBank accession numbers: EF204594.1, EF204593.1, 
EF204592.1). 
1
10
100
1000
0 1 2 3 4 5 6 7
Log10 H. suis bacteria added per gram
N
u
m
b
er
o
f
H
. 
su
is
 b
ac
te
ri
a 
d
et
ec
te
d
 b
y
E
M
A
 q
P
C
R
Chapter 1 
78 
 
4. Discussion 
To our knowledge, this study is the first to describe a technique that enables quantification of 
live H. suis bacteria in pig meat. Since RT-PCR, known to be a highly sensitive method for 
the quantification of foodborne pathogens, cannot distinguish amplified DNA derived from 
live or dead bacteria, this technique was combined with EMA staining. By treating bacterial 
samples with EMA before PCR, only DNA from viable cells was amplified, since EMA 
selectively binds to DNA of dead microorganisms. This detection method was first described 
by Nogva et al. (2003) and ever since, multiple optimizations for various microorganisms 
have been described ( Nam et al., 2011, Qin et al., 2012 and Rueckert et al., 2005). However, 
DNA amplification from viable bacterial cells can be partly suppressed by EMA treatment 
resulting in an underestimation of the number of viable cells ( Cawthorn and Witthuhn, 2008, 
Nocker and Camper, 2006, Nocker et al., 2006 and Kobayashi et al., 2009), as was shown in 
the present study when concentrations higher than 50 μg ml− 1 were used. On the other hand, 
by treating bacterial suspensions once with EMA at concentrations below 50 μg ml− 1, 
insufficient differentiation between viable and dead bacteria occurred (data not shown). To 
overcome these limitations, a double treatment with low concentrations of EMA was 
developed, as previously performed by Minami et al. (2010). 
The EMA RT-PCR was applied to spiked pork samples after 0, 24 or 48 h of cold 
storage. Survival of H. suis bacteria was ascertained up to 48 h post-experimental incubation, 
which is rather unexpected, since H. suis is known to be a very fastidious microorganism. 
Possible environmental factors contributing to survival of H. suis (under the conditions 
described in the Materials and methods section) are the presence of a moist environment and a 
low oxygen tension. Indeed, like other gastric Helicobacter species, H. suis prefers 
microaerobic conditions ( Baele et al., 2008), which may have been achieved by sealing the 
sample recipients. In addition, survival of H. pylori has been observed in aqueous or moist 
environments ( Bellack et al., 2006, West et al., 1992 and Böhmler et al., 1996). 
In two out of 50 retail minced pork samples, DNA from viable H. suis bacteria was 
detected with the EMA RT-PCR method, demonstrating the presence of low concentrations of 
viable bacteria. It has been described that the prevalence of Salmonella enterica in minced 
pork ranges from 0.3 to 4.3%, with a contamination level of − 2.35 log(10) ± 1.09 CFU g− 1 ( 
Delhalle et al., 2009), indicating that the contamination level might be similar for both 
pathogens. A comparable percentage (2.5%) of minced pork samples are contaminated with 
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Campylobacter bacteria with a contamination level ranging from − 1.40 to 
− 0.02 log(10) CFU g− 1 ( Ghafir et al., 2007). 
All results combined, suggest that transmission of H. suis bacteria to humans through 
contaminated pork might occur, indicating that this micro-organism might act as a foodborne 
pathogen, especially since the dose required to infect humans is unknown. 
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Abstract 
Helicobacter (H.) suis is a world-wide spread pathogen which not only colonizes the stomach 
of pigs, but is also the most prevalent gastric non-H. pylori Helicobacter (NHPH) species in 
humans. H. suis infections are associated with gastric lesions both in pigs and in humans. 
Recently, the presence of viable H. suis bacteria has been demonstrated in minced pork, 
suggesting that manipulation or consumption of contaminated pig meat is a possible route of 
transmission of this zoonotic agent. The main goal of this study was to determine the extent of 
pork carcass contamination with H. suis at slaughter. In two consecutive studies, the 
occurrence of H. suis DNA was assessed in scalding water, head and mouth swabs, 
mesenteric lymph nodes, palatine tonsils and on the chest, shoulder and ham region of pork 
carcasses from three slaughterhouses using qPCR with ureA gene based H. suis-specific 
primers. H. suis DNA was detected on carcasses in all slaughterhouses, in 8.3% of all 1083 
samples. It was found in all sampled matrices, except for the palatine tonsils and scalding 
water samples. Contamination levels of dressed pork samples did not exceed 184 genomic 
equivalents per 100 cm
2
 (shoulder, ham) or 300 cm
2
 (chest). All positive PCR products were 
subjected to sequence analysis of the ureA gene to confirm the identification of H. suis 
bacteria. Using multilocus sequence typing (MLST) on a selection of the positive samples, 5 
unique sequence types (STs) could be assigned. Multiple H. suis strains were present on 
samples derived from one specific pig herd. Since H. suis DNA was detected in 11% (n: 90) 
of the mesenteric lymph nodes derived at the slaughterhouse, it was determined whether these 
organisms can colonize the mesenteric lymph nodes after experimental infection. Despite 
high-level colonization of the porcine stomachs with the H. suis strain, no H. suis DNA was 
detected in the mesenteric lymph nodes at four weeks after experimental infection. This might 
indicate that its presence in these tissues of slaughtered pigs is due to contamination during 
the slaughter process, but further studies are necessary to confirm this. In conclusion, we 
demonstrate a relatively high prevalence of H. suis on pork carcasses. 
  
Chapter 2 
86 
 
1. Introduction 
In 1990, Queiroz et al., studied the role of pigs as a possible reservoir for Helicobacter (H.) 
pylori-like organisms. Instead of H. pylori-like organisms, not previously described Gram 
negative, large spiral-shaped bacteria were found in the mucus layer of lumen and antral pits 
of the pig stomachs. Initially, the name “Gastrospirillum suis” was proposed. Subsequent 
characterization, however, showed that this bacterium belonged to the genus Helicobacter (De 
Groote et al., 1999) and after the first successful in vitro isolation, the name H. suis was 
accepted (Baele et al., 2008). H. suis bacteria have been detected in up to 60% of pig 
stomachs, with prevalences depending on the age of the animals, as well as on the geographic 
region (Hellemans et al., 2007 and Kopta et al., 2010). Pigs, however, are not the only 
possible hosts for H. suis bacteria. These organisms have been detected in human gastric 
biopsies more frequently than any of the other gastric non-H. pylori Helicobacter (NHPH) 
species causing gastric diseases such as gastritis, gastric ulcers and gastric cancer (Debongnie 
et al., 1995, Debongnie et al., 1998, Haesebrouck et al., 2009, Joo et al., 2007 and Morgner et 
al., 1995). 
The exact routes of transmission from pigs to humans remain unclear. Recently, the 
presence of viable H. suis bacteria has been reported in minced pork, suggesting that 
manipulation or consumption of contaminated pork is a possible route of transmission of H. 
suis bacteria (De Cooman et al., 2013). To date, there are no other studies reporting the 
occurrence of H. suis bacteria in pork and no information on carcass contamination is 
available. The contribution of food of animal origin to human infection with H. suis therefore 
remains unclear. 
The main aim of this study was, therefore, to investigate H. suis occurrence on pork 
carcasses. Samples were taken at seven stages of slaughter, in three abattoirs, and examined 
quantitatively for the presence of H. suis DNA. Multilocus sequence typing (MLST) was used 
to obtain insight in the heterogeneity of the H. suis population present on pork carcasses. 
2. Materials and methods 
2.1. Sample collection and preparation 
The slaughter process, which is generally standardized in all Belgian slaughterhouses, is as 
follows. After stunning, the animals are secured by the hind legs to an overhead conveyer rail. 
The gas or electric stunned animals are stuck immediately by cutting the main blood vessel in 
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the chest. After bleeding, the animals are scalded and dehaired mechanically. The pigs are 
then secured to the overhead conveyer, singed by gas burners, eviscerated, and next cut along 
the midline by using an automatic splitting saw. 
In a first study, 363 samples originating from three pig herds were collected in three 
different Belgian abattoirs (A, B, C). The samples were taken at five sampling points, but 
without following the same carcasses through the slaughter process. In each slaughterhouse, 
30 samples from the head and 30 samples from the mouth were collected immediately after 
automatic splitting of the carcasses, using cotton swabs (Cultiplast®, LP Italiana Spa, Milano, 
Italy) which were moistened in buffered peptone water. Furthermore, 30 mesenteric lymph 
nodes were removed immediately after evisceration and placed into sterile plastic bags for 
transport to the laboratory. In the lab, the surface of the lymph nodes was seared and cut 
aseptically into small pieces. Next, the lymph nodes were homogenized and 40 mg was 
transferred into 1.5 ml Eppendorf tubes, which were then kept at − 20 °C until DNA 
extraction. Thirty palatine tonsils were excised and treated the same way as the lymph nodes. 
Finally, 2 l of scalding water was collected from each slaughterhouse, after at least 2 h of 
slaughter activities. 
A second study was carried out in slaughterhouse C that was visited on three 
occasions. On each occasion, all samples originated from only one pig herd, but again without 
following the same carcass through the slaughter process. Each time, 30 mesenteric lymph 
nodes were collected immediately after evisceration, 30 samples from the mouth were taken 
after mechanical splitting and 30 samples were collected from the ham, shoulder and chest 
region of carcasses on the slaughterline and once again of carcasses after 6 h of chilling by 
forced ventilation. Mesenteric lymph nodes were treated as described above. For collection of 
samples from the mouth and the carcasses, sponge-sticks (3M™ Sponge-Sticks, St. Paul, 
USA) were used, which were moistened in 10 ml buffered peptone water. A 100 cm
2
 area of 
the ham and shoulder and a 300 cm
2
 area of the chest was sampled, according to the EU 
Decision 2001/471/EC of 8 June 2001. All mouth and carcass samples were stored in plastic, 
sterile bags at − 20 °C until DNA extraction. 
2.2. DNA extraction 
Head and mouth swabs, collected during the first study, were placed in Eppendorf tubes, 
containing 250 μl buffered peptone water. After vortexing for 1 min, the swabs were placed in 
tips, which were then placed in Eppendorf tubes, and then centrifuged at 9300 ×g for 5 min. 
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The obtained pellet was kept and 100 μl Prepman Ultra (Invitrogen, Carlsbad, CA, USA) was 
added. Further conditions used for DNA extraction, were according to the manufacturer's 
protocol. 
One liter of each scalding water sample, collected during the first study, was filtered 
using the PowerWater® DNA Isolation kit (Mobio Laboratories, Inc., Carlsbad, USA), 
applying small adaptations to the protocol, using a 0.22 μm filter membrane and adding an 
additional centrifugation step at 800 ×g for 5 min. 
For DNA extraction from the tonsils and mesenteric lymph nodes, collected during the 
first and second study, the Isolate Genomic DNA Mini Kit (Bioline, London, UK) was used, 
following the manufacturer's instructions for isolation of DNA from animal tissue. 
The mouth and carcass samples that had been collected during the second study and 
stored in plastic bags, were defrosted overnight at 4 °C. Then, 10 ml of buffered peptone 
water was added and the samples were homogenized in a stomacher for 90 s. Thereafter, most 
of the fluid was recovered from the bags and placed into 15 ml Falcon tubes for centrifugation 
(30 min at 3724 ×g). The obtained supernatant was removed, and 50 μl of PrepMan Ultra 
(Invitrogen) was added to the pellet. DNA extraction was performed according to the 
manufacturer's instructions. 
2.3. Quantitative polymerase chain reaction 
After DNA extraction, quantitative polymerase chain reaction (qPCR) was performed on all 
samples, using the same primers (UreSu 531 FW and UreSu 783 RV) and conditions as 
described by De Cooman et al. (2013). Briefly, qPCR involved an initial cycle at 95 °C for 
15 min, followed by 40 cycles of denaturation (at 95 °C for 20 s), primer annealing (at 60 °C 
for 30 s) and chain extension (at 73 °C for 30 s). An external standard, comprising tenfold 
dilutions of a 1541 bp ureA–ureB gene segment, was used starting at 105 amplicons for each 
10 μl of reaction mixture. The copy number concentration was calculated based on the 
expected length of the amplicon and its dsDNA amount. Sequences of the primers used, are 
given in Table 1. Both standard and samples were run in duplicate. Sequence analyses of the 
ureA gene were performed on 21 positive PCR-products to confirm the identification of H. 
suis bacteria. 
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Primer Sequence (5′ to 3′) Amplicon size (bp) 
UreSu 531 FW 
UreSu 783 RV 
CACCACCCCGGGGAAGTGATCTTG 
CTACATCAATCAAATGCACGGTTTTTTCTTCG 
253 
UreSu 428 FW 
UreSu 1968 RV 
GGTGTTGCCCATATGATTCA 
CGAATCCTAGAGTCAGCAA 
1541 
 
Table 1. Oligonucleotide primers used for amplification and quantitation (UreSu 531 FW and 
UreSu 783 RV) and establishing an external standard (UreSu 428 FW and UreSu 1968 RV) 
(De Cooman et al., 2013). 
 
2.4. Multilocus sequence typing 
The five mouth swab samples with the highest quantity of H. suis equivalents on qPCR 
(originating from two pig herds of the second study) were selected for further typing using 
multilocus sequence typing (MLST). The variable regions of seven housekeeping genes 
(atpA, efp, mutY, ppa, trpC, ureAB and yphC) were amplified and sequenced according to the 
method described by Liang et al. (2013). Amplification was established with Accuzyme DNA 
polymerase, using the same conditions as previously described. Purification of PCR products 
and sequencing were performed by GATC Biotech (Cologne, Germany). Electropherograms 
were exported and converted to Kodon software (Applied Maths, Sint-Martens-Latem, 
Belgium). 
2.5. Experimental H. suis infection in pigs 
Twenty-four pigs were inoculated with H. suis strain HS1 (Baele et al., 2008) at the age of 
four weeks. All animals received 10
9
 to 2 × 10
9
H. suis bacteria per os twice, with an interval 
of 48 h. At the age of eight weeks, the animals were euthanized and stomach samples were 
collected from the mucosa of the antrum, corpus and fundus, from each animal, as well as 3 
mesenteric lymph nodes (one close to the stomach, one close to the jejunum and one close to 
the rectum). DNA was extracted from these samples, using the protocol described above for 
the tonsils and mesenteric lymph nodes. DNA extracts were frozen at − 20 °C until further 
analysis. For the detection of H. suis DNA, qPCR was performed using the same primers and 
conditions as described before. 
All laboratory animal experiments were approved by the Animal Care and Ethics 
Committee of the Faculty of Veterinary Medicine, Ghent University. 
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3. Results 
3.1. Detection of H. suis DNA on pork carcasses at slaughter 
In the first study, H. suis DNA was detected in samples from all three slaughterhouses, in 
10% of the head swabs (n: 90), 14.4% of the mouth swabs (n: 90) and 13.3% of the 
mesenteric lymph nodes (n: 90) (Table 2). No H. suis DNA was detected in the palatine 
tonsils and scalding water samples. 
Table 2. Presence of H. suis DNA on pork carcasses using H. suis-specific primers (first 
study). 
  
Mouth 
swabs 
Head 
swabs 
Mesenteric 
lymph nodes 
Palatine 
tonsils 
Scald tank 
water 
Slaughterhouse A 
Number of 
positive samples 
6 (n:30) 4 (n: 30) 3 (n: 30) 0 (n: 30) 0 (n: 1) 
Mean number of 
bacteria detected 
1.4 × 10
2
/ml 3.1 × 10
1
/ml 9.0/mg 0/mg 0/ml 
Slaughterhouse B 
Number of 
positive samples 
4 (n: 30) 4 (n: 30) 6 (n: 30) 0 (n: 30) 0 (n: 1) 
Mean number of 
bacteria detected 
2.5 × 10
2
/ml 8.6/ml 2.8 × 10
1
/mg 0/mg 0/ml 
Slaughterhouse C 
Number of 
positive samples 
3 (n: 30) 1 (n: 30) 3 (n: 30) 0 (n: 30) 0 (n: 1) 
Mean number of 
bacteria detected 
1.8 × 10
1
/ml 2.1/ml 0.34/mg 0/mg 0/ml 
In the second study, H. suis DNA was detected in all five dressed pork carcass areas, both 
before and after chilling. Overall, 7.8% of the 720 samples contained H. suis DNA. The 
mouth and chest were identified as the two most frequently contaminated areas pre-chilling 
and shoulder and chest areas post-chilling (Table 3). 
Table 3. Comparison of PCR-positive pork carcass samples by sampling area on 3 different 
occasions (I, II and III; second study). 
 
Number of positive samples at: 
 
Total 
Mouth 
Ham 
bc
a
 
Chest 
bc 
Shoulder 
bc 
Shoulder 
ac
b
 
Chest 
ac 
Ham ac Lnn. 
I 8 (n: 30) 2 (n: 30) 0 (n: 30) 0 (n: 30) 1 (n: 30) 0 (n: 30) 0 (n: 30) 3 (n: 30) 14 (n: 240) 
II 9 (n: 30) 1 (n: 30) 5 (n: 30) 2 (n: 30) 1 (n: 30) 2 (n: 30) 1 (n: 30) 3 (n: 30) 24 (n: 240) 
III 6 (n: 30) 2 (n: 30) 2 (n: 30) 3 (n: 30) 1 (n: 30) 0 (n: 30) 0 (n: 30) 4 (n: 30) 18 (n: 240) 
Total 23 (n: 90) 5 (n: 90) 7 (n: 90) 5 (n: 90) 3 (n: 90) 2 (n: 90) 1 (n: 90) 10 (n: 90) 56 (n: 720) 
 
a 
bc: before forced ventilation chilling.
 
b 
ac: after 6 h of forced ventilation chilling. 
Chapter 2 
91 
 
Quantitative examination of the samples revealed 4.1 to 103.0 genomic equivalents of H. suis 
per 100 cm
2
 (shoulder and ham) or 300 cm
2
 (chest) for the samples taken before chilling and 
approximately 2.9 to 184.0 genomic equivalents of H. suis per 100 or 300 cm
2
 for the swabs 
taken after forced air chilling. 
Sequence analyses confirmed that all positive PCR-products contained H. suis DNA. 
3.2. Multilocus sequence typing 
H. suis from five mouth swabs from two pig herds were analyzed for genetic relatedness 
using MLST. Hereby, five different sequence types (STs) were identified, of which none had 
been previously included in the PubMLST database. No ST was found in more than one pig 
herd. Within the same pig herd, two to three different STs were found (Table 4). 
Table 4. Determination of allele numbers and sequence types for 5 H. suis strains present on 
mouth swabs derived from two pig herds (p1 and p2) 
 
atpA efp mutY ppa trpC ureA yphC 
Lie-1 (p1 mouth 18) 1 2 11 2 1 5 7 
Lie-2 (p1 mouth 27) 1 4 11 1 1 1 3 
Lie-8 (p2 mouth 4) 4 2 11 1 1 1 1 
Lie-9 (p2 mouth 5) 1 2 11 1 2 1 3 
Lie-10 (p2 mouth 17) 1 2 11 1 2 1 1 
 
3.3. Absence of H. suis DNA in mesenteric lymph nodes after experimental infection 
Twenty three out of the twenty four orally inoculated pigs tested positive for the presence of 
H. suis DNA in the gastric mucosa. The two most frequently colonized regions were the 
antrum and the fundic gland region, with mean densities of 1.8 × 10
7
 and 1.3 × 10
7
 
bacteria/mg tissue respectively. In contrast, in none of the mesenteric lymph nodes H. suis 
DNA was detected. 
4. Discussion 
H. suis is a very fastidious micro-organism requiring a highly enriched biphasic medium at 
pH 5 and a microaerobic atmosphere (Baele et al., 2008). Up till now, isolation of this agent 
has been only successful from the gastric mucosa of pigs strongly colonized with this micro-
organism and even from this tissue, it is a long and laborious process (Vermoote et al., 2011). 
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As it is not feasible to isolate these bacteria from other matrices, such as carcass samples, 
qPCR was used during this study for the detection of H. suis DNA. 
To our knowledge, this is the first report describing the presence of H. suis DNA on 
pork carcasses at slaughter. An overall prevalence of 4.3% on dressed pork carcasses was 
detected, which is comparable to that of well-known zoonotic bacteria such as Salmonella 
(1.9%–6%), Yersinia (0–0.3%) and Campylobacter (8.8%) (Bohaychuk et al., 2011, Bonardi 
et al., 2003, Davies et al., 2000, Gürtler et al., 2005, Käsbohrer et al., 2000 and Nauta et al., 
2013). Besides, the H. suis genomic equivalents on the contaminated carcasses were in the 
range of those for Campylobacter (Ghafir et al., 2007). This further indicates that 
contaminated pig meat may constitute a source of H. suis infection for humans. 
Considering that the pork carcasses were scalded at 58 °C, followed by singeing by 
gas burners prior to evisceration, one could hypothesize that carcass contamination is due to 
spilling of the stomach content during evisceration. This might explain why the chest and 
shoulder regions were more frequently contaminated than the ham. Another possibility is that 
the carcass is contaminated during splitting, when the splitting saw reaches the mouth of the 
pigs. The oral cavity may already be contaminated by regurgitation after securing the pigs 
upside down to an overhead conveyer rail. Contamination of carcasses by spilling intestinal 
content during evisceration, as for example has been suggested for Salmonella enterica 
(Bonardi et al., 2013) and Arcobacter spp. (Ohlendorf and Murano, 2002 and Van Driessche 
et al., 2004), is rather unlikely, since H. suis DNA has never been identified in feces after 
experimental infection of pigs (unpublished results). 
Although H. suis DNA was detected in 13.3% of mesenteric lymph nodes of slaughter 
pigs, its presence in mesenteric lymph nodes of pigs at four weeks after experimental 
infection with H. suis was not demonstrated. These data suggest that the presence of H. suis 
DNA in mesenteric lymph nodes is not a result of tissue colonization, but rather occurs during 
slaughter. On the other hand, long term colonization studies of mice with the closely related 
H. heilmannii, have shown migration of these bacteria in macrophages to lymphoid tissue 
along the gastro-intestinal tract (unpublished results). Further studies are necessary to 
determine if this also occurs in pigs colonized with H. suis for longer periods of time. 
By performing MLST on five selected samples, a high diversity among the strains 
derived from the same pig herd and all slaughtered in the same abattoir was demonstrated. 
This indicates that the contamination of carcasses does not originate from the slaughterhouse 
environment. 
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Cooling combined with drying reduced the number of detectable H. suis genomic 
equivalents on the pork carcasses. This reduction might be caused by firm adhesion of the 
bacteria on the skin. Alternatively, the bacteria may be able to shelter in the hair follicles and 
can therefore not be reached by swabbing, as has been demonstrated for many 
microorganisms by Cason et al. (2004). In other related microaerophilic bacteria such as 
Arcobacter spp. (Van Driessche and Houf, 2007) and Campylobacter spp., as well as in 
Salmonella enterica (Epling et al., 1993 and Oosterom et al., 1985) forced cooling is not fully 
capable of eliminating carcass or environmental contamination. Further research is necessary 
in order to assess the actual risk imposed to consumers of pork and to identify the exact 
route(s) of contamination during the slaughter process. 
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Abstract 
Helicobacter (H.) suis is the most prevalent non-H. pylori Helicobacter (NHPH) species 
colonizing the stomach of humans. Development of a H. suis-specific serological test would 
seriously simplify the diagnosis in humans. In order to investigate the feasibility of such a test, 
H. suis-specific antigens were identified by performing two-dimensional gel electrophoresis 
of H. suis proteins present in whole-cell lysate and one-dimensional gel electrophoresis of H. 
suis proteins recombinantly expressed in Escherichia coli, followed by immunoblotting with 
sera from human patients infected with either H. suis, H. heilmannii or H. pylori. Several H. 
suis whole-cell lysate derived protein spots between ~20 kDa and ~30 kDa and at ~60 kDa 
were only recognized by the serum of an H. suis infected patient. The small subunit (20 kDa) 
of H. suis γ-glutamyl transpeptidase was recognized by sera of H. suis or H. heilmannii 
infected humans, but not by sera from H. pylori infected patients. These results indicate that 
development of a serological test allowing to differentiate NHPH or H. suis infected patients 
from patients infected with H. pylori is feasible. 
Keywords 
Non-Helicobacter pylori helicobacters, Helicobacter suis, zoonotic agent, immunoproteomics, 
serodiagnosis 
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1. Introduction 
Helicobacter (H.) pylori has been recognized as an important factor in the development of 
gastric disease in humans (Atherton, 1997; De Luca and Iaquinto, 2004; Cover and Blaser, 
2009). Bacterial gastric disorders in humans have, however, also been associated with non-
Helicobacter pylori helicobacters (NHPH), with a prevalence ranging between 0.2 and 6% 
(Haesebrouck et al., 2009). Of all NHPH, H. suis is the most frequently diagnosed species in 
human gastric mucosal specimens. H. suis, a large spiral-shaped bacterium, primarily 
colonizes the stomach of pigs worldwide, with a prevalence often exceeding 60% in pigs at 
slaughter age (Hellemans et al., 2007; Baele et al., 2008; Haesebrouck et al., 2009). Direct or 
indirect contact with pigs is considered to be the main infection route for humans 
(Haesebrouck et al., 2009). Recently, viable H. suis bacteria were detected in pork, indicating 
that this agent might also be transferred to humans through the food chain (De Cooman et al., 
2013). 
H. suis infected humans may not only develop gastritis and peptic ulcer disease, but 
they have been shown to carry a higher risk of developing gastric mucosa-associated 
lymphoid tissue (MALT) lymphoma, compared to H. pylori infected humans (Stolte et al., 
1997; Debongnie et al., 1998; Morgner et al., 2000; Stolte et al., 2002). At present, various 
tests for the diagnosis of H. pylori infections are readily available. The diagnosis of NHPH 
infections, however, is often hampered by the focal distribution of the bacteria in the stomach 
and the very fastidious nature of these species. For example, the accuracy of Urea Breath tests 
may be lower than is the case for H. pylori infected patients (Haesebrouck et al., 2009; 
Matsumoto et al., 2014). Furthermore, microscopic visualization of NHPH microorganisms is 
difficult and the morphological differences between NHPH species are in general not obvious 
(Debongnie et al., 1994; Happonen et al., 1998). At present, no test for the identification of 
antibodies against NHPH in blood samples of humans or animals is available. Obviously, 
there is a need for a simple and reliable tool to diagnose NHPH infections, preferably with 
identification up to the species level. In order to obtain the knowledge needed to develop an 
antigen-based H. suis-specific diagnostic test, H. suis-specific antigens that are recognized by 
antibodies of infected human patients need to be identified.  
The present study aimed at identifying H. suis-specific antigenic proteins eliciting an 
immune response in infected humans, thus holding promise as potential target proteins for 
species-specific diagnosis. Two approaches were used. In a first series of experiments, 
immunogenic protein patterns of whole bacterial cell lysates were compared after probing 
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with sera from human patients infected with H. suis, H. heilmannii or H. pylori. In a second 
approach, the reaction of these sera was studied against three specific H. suis proteins which 
were recombinantly expressed in Escherichia coli: urease subunit B (UreB), neutrophil-
activating protein A (Nap A) and gamma-glutamyl transpeptidase (GGT). These proteins 
were chosen because they are considered to play a role in the interaction of H. suis with its 
hosts (Flahou et al., 2011; Vermoote et al., 2011; Zhang et al. 2015).  
2. Materials and methods 
 
2.1. Bacterial strains 
In the following experiments, H. suis strain HS5bLP (HS5, GenBank: ADHO00000000), H. 
heilmannii ASB1.4 (Genbank: HE984298), H. bizzozeronii R1051 and the Sydney strain of H. 
pylori (strain SS1) were used. H. suis strain HS5bLP (Liang et al., 2015) was isolated from 
the stomach of a sow, according to the method described by Baele et al. (2008). H. heilmannii 
ASB1.4 was isolated from the gastric mucosa of a kitten with severe gastritis (Smet et al., 
2013) and H. bizzozeronii strain R1051 was isolated from canine gastric biopsies (Hänninen 
et al., 1996). The Sydney strain of H. pylori (strain SS1) shows a high colonizing ability in 
mice (Lee et al., 1997). 
2.2. Patients 
A total of 118 patients undergoing upper gastroscopy for gastrointestinal complaints, such as 
dyspepsia, stomach ache, halitosis or vomiting, were recruited for this study. Patients who had 
received any antimicrobial therapy during the 4 weeks prior to gastroscopy, or who received 
active immunosuppressive therapy, were excluded from this study. All experiments were 
approved by the Ethics Committee of Ghent University (2011/393) and the local Ethics 
Committee of the Maria Middelares hospital. After consent to participation in this study, 10 
mL venous blood was collected from each patient and, after centrifugation, sera were gathered 
and stored at -20°C until further examination. During gastroscopy, biopsy specimens were 
obtained from the antrum, corpus and duodenal region, and stored at -20°C in an Eppendorf 
tube, containing 600 µL ethanol. 
2.3. DNA isolation and quantification  
DNA extraction from the biopsy specimens was performed by using the DNeasy Tissue kit 
according to manufacturer‟s instructions (Qiagen, Valencia, CA). After DNA extraction, a 
Chapter 3 
102 
 
nested polymerase chain reaction (PCR) was performed, using the primers and conditions as 
shown in Table 1. Sequence analysis was performed on any positive PCR product, to further 
identify the gastric helicobacters up to the species level.  
Table 1. All human stomach biopsy specimens were subjected to a nested PCR, in order to 
detect a fragment of the urease gene. During the first run, primers developed by O‟Rourke et 
al. (2004)* were applied. The conditions used during the second run, were described by 
Flahou et al. (2014)**. 
  Primer FW Primer RV PCR-conditions  
O'Rourke*  SOL U430 SOL 1735 5' 94°C  
  gCK gAW TTg ATg CAA gAA gg CTT CgT gRA TTT TAA RRC CAA T 35 x (1' 94°C - 1' 52°C - 1' 72°C) 
    5' 72°C  
      
UreNHPH_short**  UreNHPH_shortF UreNHPH_shortR 5' 94°C  
  CDg TRM gNT TTg ARC CNg g gTD gTD ggD CCr Tac ATW gA 40 x (1' 94°C - 1' 57°C - 1' 72°C) 
    5' 72°C  
 
2.4. Serum samples 
In a previous study, Joosten et al. (2013) diagnosed a H. suis infection in a pig veterinarian, 
suffering from reflux oesophagitis and dyspepsia. A blood sample of this patient, as well as 
samples of any patient for whom a gastric Helicobacter infection was identified during the 
current study, were included. After centrifugation of the blood samples (1000xg, 4°C, 10 min), 
sera were collected and frozen at -70°C until further use. Serum originating from a patient 
without previous history of gastric upset and for whom no Helicobacter DNA was found 
during examination of gastric biopsy specimens, was included as a negative control. As a 
positive control for H. suis infection, pooled sera from mice, intranasally immunized with H. 
suis whole-cell lysate, were used (Vermoote et al., 2012).  
2.5. Two-dimensional gel electrophoresis (2D-PAGE) 
H. suis HS5bLP, H. heilmannii ASB1.4, and H. bizzozeronii R1051 strains were grown on 
their respective biphasic medium, as described previously (Flahou et al., 2010; Smet et al., 
2012). Once a volume of 50 mL was obtained for each of the three strains, with a 
concentration of 10
6
-10
8
 bacteria per mL, the bacteria were harvested by centrifugation (5000 
xg, 4°C, during 10 min), and 4 washing steps with Hank‟s Balanced Salt Solution (HBSS) 
were performed. H. pylori SS1 was grown on Brain Heart Infusion (BHI) agar supplemented 
with 10% horse blood and Vitox supplement (Oxoid, Basingstoke, UK). Cultures were 
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harvested by washing all culture plates with HBSS, obtaining a volume of 50 mL, with a 
concentration of 10
6
-10
8
 bacteria per mL. The ReadyPrep™ Sequential Extraction Kit (Bio-
Rad, Hercules, CA, USA) was used to extract both soluble and insoluble proteins from each 
of the four bacteria (Vermoote et al., 2012). Next, the protein concentration was determined 
using the Bradford protein quantification method (Bradford Protein Assay (Bio-Rad, Hercules, 
CA, USA)). All proteins were stored at -70°C until further use.  
In parallel, a total of 100 µg of HS5bLP, ASB1.4, R1051 and SS1 proteins were 
transferred into LoBind Eppendorf tubes (Eppendorf AG, Hamburg, Germany). Next, 160 µl 
rehydration buffer (7M ureum, 2M thioureum, 2% CHAPS, 0.2% carrier ampholyte pH 3-4, 
100 mM dithiothreitol (DTT) and bromophenol blue) was added to each Eppendorf tube. 
Each solution was passively absorbed onto a ReadyStrip™ (IPG Strips, 11 cm, pH 3-10, Bio-
Rad) during 6 h, after which iso-electric focusing was performed in a Protean IEF Chamber 
(Bio-Rad) as described by Van Steendam et al. (2010). Each strip was then set to equilibrate, 
during 15 min, in 1.5% DTT in equilibration buffer (50 mM TrisHCl, pH 8.8 6 M urea, 20% 
glycerol, 2% SDS), and next, in 4% iodoacetamide in equilibration buffer during another 15 
min. Then, gel electrophoresis was performed on a 10% TrisHCl SDS-PAGE, at 150 V during 
20 min, followed by 60 min at 200V. For each gel which was run to be immunoblotted 
afterwards, another gel was performed in parallel. The latter was first fixed in 10% MeOH, 7% 
acetic acid, and next stained with Sypro® Ruby Protein Gel staining (Bio-Rad). After staining, 
HS5bLP, ASB1.4, and R1051 proteins were visualized on the respective gels, using the 
VersaDoc Imaging System (Bio-Rad).  
2.6. 2D Western blotting  
Proteins were transferred from the gels to a nitrocellulose membrane (Bio-Rad), as described 
previously (Van Steendam et al., 2010). Membranes were treated with 5% nonfat dry milk 
Blotting-Grade blocking buffer (Bio-Rad), and incubated overnight (ON) with a 1/200 serum 
sample diluted in blocking buffer. After washing the membranes with 0.3% Tween-20 (Bio-
Rad) diluted in PBS, they were incubated for 1 h with goat anti-human immunoglobulin G 
(IgG), or in case of the positive control murine serum, with goat anti-mouse IgG conjugated 
with horseradish-peroxidase (HRP) (1/1000 diluted in blocking buffer, Pierce, Rockford, IL, 
USA). After two washing steps with 0.3% Tween-20 of 5 min each, membranes were treated 
with Supersignal West Dura Extended Duration Substrate (Pierce). Next, patterns were 
visualized, using the VersaDoc Imaging system.  
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2.7. In-Gel Digestion and LC-MS/MS Analysis  
In-gel digestion of proteins was performed as described by Cheung et al. (2009). 
Identification of the peptides was performed, as previously described by Van Steendam and 
co-workers (2012), using the TripleTOF 5600 (ABSciex) appliance. Data analysis was 
performed by automated database searching (MASCOT Daemon 2.3., Matrix Science, 
London, UK) against the H. suis protein database from NCBI. Peptide mass tolerance and 
fragment mass tolerance was set at 25 ppm and 0.2 Da, respectively. Maximum two 
miscleavages were allowed. Proteins were only considered to be correctly annotated when the 
significance was below 0.01 (p < 0.01) and at least three peptides passed the required bold red 
criteria from Mascot Daemon, indicating that at least three peptides had rank 1 and a 
significance below 0.01. 
2.8. Preparation of recombinant H. suis UreB, NapA and GGT  
The gene encoding the H. suis urease subunit B (UreB) (GenBank locus tag HSUHS5_0285) 
and the gene encoding the H. suis neutrophil-activating protein A (NapA) sequence (GenBank 
locus tag HSUHS5_0015) were amplified by PCR and cloned into the pET-24d vector and the 
pENTR™/TEV/D-TOPO® vector, respectively (with a transfer from the latter into the 
pDEST17™ destination vector). The obtained rUreB was expressed in E. coli strain BL21 
(DE3) and the rNapA in E. coli strain BL21-AI™, using the E. coli Expression System with 
Gateway® Technology (Invitrogen, Carlsbad, CA, USA). All conditions used to perform 
expression of UreB and NapA proteins, were previously described by Vermoote and co-
workers (2012). The γ-glutamyl transpeptidase (GGT) of the HS5bLP strain (GenBank  
GU972556) was expressed in the E. coli Expression System with Gateway® Technology, as 
described elsewhere (Flahou et al., 2011). rUreB, rNapA and rGGT protein concentrations 
were determined with the RC DC Protein Assay (Bio-Rad). 
2.9. One-dimensional gel electrophoresis (1D-PAGE) and Western blotting of H. suis 
rUreB, rNapA and rGGT 
1D-PAGE was performed using 10% polyacrylamide TGX™ precast gels (Bio-Rad). Briefly, 
10 µg rUreB, rNapA or rGGT was diluted (1:1) in 2x Laemmli sample buffer (Bio-Rad), and 
loaded into each well of the precast gel. Gels were run at 300 V for 25 min, using 25 mM Tris, 
192 mM glycine, 0.1% SDS, pH 8.3 as a running buffer. Staining of the gels and blotting 
procedures were done as described above. 
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3. Results 
 
3.1. Diagnosis of gastric Helicobacter infections 
During the current study, H. heilmannii infection was identified by performing nested PCR 
and subsequent sequence analysis in a male patient, suffering from dyspepsia, halitosis and 
nausea. Furthermore, in 18 of 118 (15%) patients, H. pylori infection was identified by PCR 
and DNA sequence analysis. Blood samples from the H. heilmannii and 5 H. pylori infected 
patients, as well as from the previously identified H. suis infected patient (Joosten et al.,2013) 
were collected before an anti-Helicobacter therapy was initiated.  
3.2. H. suis, H. heilmannii, H. bizzozeronii and H. pylori immunoproteomics  
Whole-cell proteins from H. suis strain HS5bLP were initially separated on 2D-PAGE. Fig 
1A shows the complex 2D profile of HS5bLP extracted proteins after Sypro® Ruby Protein 
Gel staining (Bio-Rad). The protein spots were separated over a molecular weight (Mr) range 
of 20-120 kDa and a pI range of 3-10. The representative 2D-immunoblot probed with serum 
of the H. suis infected patient, is shown in Fig 1B. Numerous protein spots were recognized 
by the H. suis infected patient‟s serum sample. In comparison, no immunoreactive pattern was 
visualized after loading serum samples from the H. heilmannii infected patient (Fig 1C). Fig 
1D shows the pattern as was visualized after loading serum obtained from one of the patients 
with H. pylori infection, with a distinct immunoreaction at ~50 kDa. Similar patterns were 
obtained for the serum samples of the other H. pylori infected patients. On the immunoblot 
probed with negative control serum, no immuno-reactive spots were observed (results not 
shown). Nine differentially expressed protein spots which showed a strong reactivity with 
serum from the H. suis-infected patient, but not with serum from patients infected with H. 
pylori or H. heilmannii,, were excised from the accompanying gel (Fig 1A), digested and 
identified by LC-MS/MS analysis (Table 2). 
During a second experiment, whole bacterial cell protein of H. heilmannii strain 
ASB1.4, H. bizzozeronii strain R1051, and H. pylori strain SS1 were separated on 2D-PAGE 
as well. After performing 2D Western blotting, the serum sample of the patient infected with 
H. suis was loaded. The resulting immunoreactive pattern was restricted to the ~50 kDa 
region, for the blots containing H. heilmannii strain ASB1.4 and H. bizzozeronii strain R1051 
proteins (Fig 2A-B). No immunoreactive pattern was visualized after loading the serum 
sample on the blot containing H. pylori strain SS1 proteins (Fig 2C). 
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Fig 1A The H. suis protein profile obtained after 2D-PAGE. Nine protein spots (1-9) were 
excised (circled in the figure), based on the results of the 2D-immunoblot loaded with serum 
from a H. suis infected pig veterinarian. No immunoreaction was detected at the same 
position on the immunoblot after loading serum samples of H. pylori or H. heilmannii 
infected patients. In table 2, the corresponding protein identifications are listed. 
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Fig 1B-1C-1D: 2D-immunoblots obtained by loading HS5bLP-protein extract, and 
subsequent probing with the serum sample from the H. suis infected patient (Fig 1B), the 
serum sample of the H. heilmannii infected patient (Fig 1C), and the serum sample of a H. 
pylori infected patient (Fig 1D). 
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Table 2 Putative identification of immuno-reactive protein-spots. The identified spots correspond to 
positions 1-9, as depicted in SDS-PAGE from figure 1A and were only found after loading the serum 
sample of the H. suis infected patient. Identification was done by LC-MS/MS and this resulted in the 
identification of more than one possible protein per spot. In this table, the most abundant protein is 
mentioned first for each spot.  
Spot nr H. suis protein  Mascot score 
1 Chaperonin GroEL  
Chaperone protein DnaK  
Flagellin B 
Urease subunit beta  
Heat shock protein 90 (HtpG)  
F0F1 ATP synthase subunit beta  
Trigger factor  
Elongation factor G 
GTP-binding TypA/BipA translation elongation factor  
Flagellin B  
2706 
1158 
344 
256 
241 
241 
202 
176 
101 
63 
2 Chaperonin GroEL  
Heat shock protein 90 (HtpG)  
Flagellin A  
ATP-binding ABC transporter  
Hypothetical protein 
Elongation factor G  
Urease subunit beta  
GTP-binding TypA/BipA translation elongation factor 
5400 
449 
433 
197 
194 
157 
96 
82 
3 chaperonin GroEL 
flagellin B 
Urease subunit beta 
heat shock protein 90 (HtpG) 
ATP-binding ABC transporter 
9367 
895 
789 
171 
81 
4 Chaperonin GroEL  
Urease subunit beta  
Flagellin B  
Transketolase A  
Leucyl aminopeptidase  
1-deoxy-D-xylulose-5-phosphate synthase  
9932 
1978 
793 
200 
169 
86 
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Aspartyl-tRNA synthetase  
Glutamine synthetase  
SPFH domain-containing protein 
68 
63 
 
5 Tellurium resistance protein TerD  
Inorganic pyrophosphatase  
Flagellin B  
Co-chaperone and heat shock protein 24  
Hypothetical protein HSUHS1_0896  
Chemotaxis protein  
2118 
417 
265 
161 
72 
68 
6 Tellurium resistance protein TerD  
Inorganic pyrophosphatase  
Flagellin B  
ATP-dependent Clp protease proteolytic subunit  
Co-chaperone and heat shock protein 24  
Leucyl aminopeptidase  
2503 
903 
585 
335 
218 
203 
7 Inorganic pyrophosphatase  
Tellurium resistance protein TerD  
ATP-dependent Clp protease proteolytic subunit  
Co-chaperone and heat shock protein 24 
Flagellin A  
Leucyl aminopeptidase  
5'-methylthioadenosine/S-adenosylhomocysteine 
nucleosidase  
1449 
1339 
307 
179 
170 
169 
131 
8 Inorganic pyrophosphatase 
Flagellin B 
Tellurium resistance protein TerD  
Co-chaperone and heat shock protein 24  
Leucyl aminopeptidase  
Adenylate kinase  
ATP-dependent Clp protease proteolytic subunit 
Peptidoglycan-associated lipoprotein precursor  
Hypothetical protein HSUHS5_0940 
5'-methylthioadenosine/S-adenosylhomocysteine 
1368 
514 
479 
466 
319 
297 
252 
210 
207 
177 
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nucleosidase  
Molybdenum cofactor biosynthesis protein  
 
145 
9 Adenylate kinase  
Inorganic pyrophosphatase  
Hypothetical protein HSUHS5_0940  
ATP-dependent Clp protease proteolytic subunit  
Transcription elongation factor GreA  
Flagellin A  
Molybdenum cofactor biosynthesis protein  
Chaperonin GroEL 
Tellurium resistance protein TerD  
Biotin carboxyl carrier protein 
Phosphoserine phosphatase (serB) 
Peptidoglycan-associated lipoprotein precursor  
Purine-binding chemotaxis protein  
Co-chaperone and heat shock protein 24  
Peroxiredoxin  
Leucyl aminopeptidase 
2-oxoglutarate-acceptor oxidoreductase subunit OorC  
1268 
760 
723 
645 
605 
568 
456 
388 
273 
258 
246 
219 
189 
178 
160 
125 
54 
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Fig 2A-C: 2D-immunoblots obtained after loading of H. heilmannii strain ASB1.4-protein 
extract (2A), H. bizzozeronii strain R1051 (2B), and H. pylori SS1 and loading with the serum 
sample of the patient infected with H. suis.  
3.3. 1D- PAGE analysis of H. suis rUreB, rNapA and rGGT  
For rUreB, reactivity was detected in the serum of the H. suis infected patient, one of the 5 H. 
pylori infected patients and the murine positive control serum, with a distinct band visible at 
~63 kDa. For rNapA, reactivity was detected for the very same serum samples as for rUreB, 
with a band visible at ~60 kDa. As previously described by Flahou and co-workers (2011), 
recombinant H. suis GGT is secreted as a pro-form (~60 kDa), which is subsequently 
autoprocessed into a large and a small subunit (~40 kDa and ~20 kDa, respectively). Immuno-
reactivity was shown for the sera of all H. pylori infected patients only at ~60 kDa, and for the 
serum of the H. heilmannii infected patient only at ~20 kDa. In comparison, a strong 
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immunogenic reaction was visualized both at ~20 kDa and ~60 kDa for the serum obtained 
from the H. suis infected patient and for the murine positive control serum (Fig 3). 
 
Fig 3: 1D-PAGE immunoblotting of H. suis rGGT, probed with serum of a patient infected 
with H. pylori (Hp), H. heilmannii (Hh), H. suis (Hs) or H. suis immunized mice (positive 
control Pc). No immunoreactivity against rGGT is seen against the ~40 kDa large subunit. 
Only in the lanes probed with serum from patients with a NHPH-infection and with the 
positive control serum, immunoreactivity is seen at ~20 kDa. Immunoreactivity at ~60 kDa 
was shown for the lanes probed with positive control serum and with sera from H. pylori and 
H. suis infected patients. 
 
4. Discussion 
The main aim of the current study was to identify serologic markers which could be of value 
in future diagnosis of H. suis infections in humans. Serological tests were of the first methods 
used for the diagnosis of H. pylori infections and are still valued ever since, especially in 
epidemiological assays (Burucoa et al., 2013). Serology is indeed the only method applicable 
for large-scale, population-based screening (Formichella et al., 2013). For H. suis, serological 
diagnosis may even be more important than for H. pylori as demonstration of H. suis in 
gastric samples is hampered by its patchy distribution in the stomach and the very fastidious 
nature of this species. The focal colonization pattern of H. suis most probably also accounts 
for the lower accuracy of Urea Breath Tests than is the case for H. pylori infected patients 
(Haesebrouck et al., 2009). 
In a first approach, we studied the reaction pattern of sera obtained from human 
patients infected with H. suis, H. heilmanni or H. pylori against proteins present in whole-cell 
Chapter 3 
113 
 
lysate of several NHPH and H. pylori. This allowed to select 9 immuno-reactive protein spots 
between ~20kDa and ~30kDa and at ~60kDa which were recognized by serum from the H. 
suis infected patient, but not by serum from patients infected with other Helicobacter species. 
For each of these spots, however, the identification by LC-MS/MS led to the correspondence 
of more than one protein on the same position in the gel and immuno-reactivity visualized on 
a blotting membrane does not necessarily result from the most abundant protein identified on 
this position. Further studies are necessary to determine the usefulness of these proteins as 
antigens in H. suis-specific serological tests. 
In our second approach, three proteins were selected for recombinant expression, 
purification and use in 1D-PAGE blots. For UreB, which is involved in acid-resistance of the 
bacteria, a marked reactivity was detected in the serum sample of the H. suis infected patient, 
the serum sample of a H. pylori infected patient, and the positive control serum originating 
from lysate-immunized mice. NapA is a putative virulence factor of H. suis that has, so far, 
been detected in all H. suis strains investigated. For this protein, reactivity was detected in the 
same serum samples as when using rUreB. These findings contrast with the results obtained 
after experimental infection of mice with H. suis, since antibodies to UreB were not detected 
in sera of these animals collected at four weeks after infection (Vermoote et al., 2012). This 
may indicate that the immune response after infection with H. suis may be host-specific or 
may depend on the infection stage.  
Immunoreactivity to H. suis GGT was also observed in the present study. Previous 
studies have identified the H. suis GGT as an important factor involved in death of gastric 
epithelial cells and modulation of the host immune response (Flahou et al., 2011; Zhang et al., 
2013). This enzyme was shown to be synthesized as a precursor enzyme of ~60 kDa, with 
subsequent processing into a large (~40 kDa) and a small subunit (~20 kDa), which has also 
been described for other bacterial GGT‟s such as the H. pylori and E. coli GGT (Suzuki and 
Kumagai, 2002; Boanca et al., 2006; Flahou et al., 2011). In the present study, H. suis GGT 
immuno-reactivity was observed when using the serum originating from the H. suis infected 
patient at ~20 kDa and ~60 kDa. The same pattern was observed in blots incubated with the 
positive control serum pool, whereas only at ~20 kDa reactivity was observed for the serum 
sample originating from the H. heilmannii infected patient and only at ~60 kDa for the serum 
samples of all included H. pylori infected patients. These observations might suggest that the 
40 kDa GGT subunit does not contain an antigenic determinant or epitope. Seen the fact that 
only the 60 kDa subunit was recognized by the sera of H. pylori infected humans, one might 
conclude that only the proenzyme presents the antigenic determinant recognized by serum 
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from H. pylori infected patients, in contrast to serum from H. suis infected patients, 
recognizing possibly the same epitope in the pro-enzyme as well as the small subunit after 
autoprocessing of the proenzyme. Formichella et al. (2013) noticed that H. pylori GGT was 
recognized in half of the patients, but described a stability problem when applying test strips, 
which was probably due to the autoprocessing of the 60-kDa precursor, which in turn 
influences the detectability of the antigen.  
Our finding that none of the sera of patients infected with H. pylori recognized the 20 
kDa subunit of the H. suis rGGT, which was recognized by human patients infected with H. 
suis or H. heilmannii as well as by sera of H. suis immunized mice, may indicate that this 
antigen might be useful to differentiate infections with NHPH from H. pylori infections in 
human patients. Combining it in a multiplex protein array with H. suis rUreB and rNapA, 
which in the present study were not recognized by the serum of the H. heilmannii infected 
patient, as well as with proteins detected in the whole-cell lysate derived spots that were 
differentially recognized by the serum of the H. suis infected patient (our first approach), 
might allow development of a H. suis-specific serological test. Such test will have to be 
validated by comparing the antibody binding patterns of sera from several H. suis infected 
patients, as well as sera from healthy subjects and patients infected with other gastric 
Helicobacter species, including H. pylori. One of the major challenges to be countered 
consists of collecting sera of human patients infected with NHPH, since such sera are not 
readily available. 
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Even though H. pylori is considered as the primary causative agent of infectious gastric 
diseases in humans, awareness of the clinical relevance of non-Helicobacter pylori 
Helicobacter (NHPH) infections has increased over the past 25 years. These infections most 
likely originate from animals, but the exact routes of transmission from animal to man remain 
unclear. In addition, the diagnosis is more complex than is the case for H. pylori infections, 
which often results in the lack of an exact species identification. In this thesis, we focused on 
the transmission, the detection and diagnosis of the most prevalent NHPH species in humans, 
H. suis. In the next paragraphs, new insights and future perspectives resulting from the present 
research will be discussed. 
1. The importance of pork in the transmission of H. suis to humans 
Only a few years ago, a new isolation method was successfully applied for the in vitro 
cultivation of H. suis from the stomach mucosa of pigs (Baele et al., 2008). Since the 
description of this method, only 20 H. suis strains have been isolated from porcine stomachs, 
which demonstrates the long and laborious process to obtain pure cultures of this fastidious 
and slow-growing microorganism. Given this low success rate from an organ which is the 
primary habitat of this micro-organism where it is usually present in high numbers, culture-
based methods are not considered as appropriate detection methods of viable H. suis bacteria 
in complex matrices, such as meat. In contrast, culture methods are considered the gold 
standard in prevalence studies of other important foodborne pathogens, such as 
Campylobacter and Salmonella, on pork carcasses and meat (Van Loock et al., 2000; Butzler, 
2004; Jasson et al., 2010). However, while bacteria used to be considered viable when they 
could be cultured, today's idea of viability assessment tends to be different, certainly since the 
existence of a viable but non culturable (VBNC) state was hypothesized (Shahamat et al. 
1989). Bacteria that have entered this state are no longer culturable from the environment, 
although they remain viable and may be capable of establishing infection in a host (Oliver, 
2005).  
In order to determine whether pork meat constitutes a possible source of H. suis 
infections for humans, a new, non-culture dependent method, which differentiates and 
quantifies viable from dead H. suis bacteria, was needed. One of the most successful recent 
approaches to detect viable bacteria using non-culture dependent methods, is based on 
bacterial membrane integrity (Nocker et al., 2007). In Chapter 1, the elaboration of such a 
technique was described, by combining qPCR with a prior ethidium monoazide (EMA) 
treatment. The main advantage of using an EMA qPCR can be found in the speed and 
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sensitivity of the molecular detection, while at the same time providing information on 
viability. Using the developed EMA qPCR, we demonstrated that H. suis survives in 
experimentally contaminated pork samples for up to 48 h. This method may prove useful for 
further studies concerning H. suis survival in different environmental conditions and matrices, 
which is vital to identify potential sources of infection. The survival of H. suis in a certain 
matrix may depend on the availability of a suitable niche with specific requirements of 
moisture and oxygen levels. Hence, it was surprising that DNA derived from viable H. suis 
bacteria was detected in minced pork at retail level. In the current study, only low 
concentrations of viable H. suis bacteria were demonstrated, which further decreased over 
time. Therefore, although survival of H. suis was demonstrated, multiplication in pork (as is 
possible for certain foodborne pathogens, such as Salmonella) is highly unlikely. Since the 
dose required to infect humans is unknown for all Helicobacter spp. and at this stage, there is 
no information on possible factors hampering or facilitating survival, no clear conclusion can 
be drawn concerning the true hazard of contaminated meat as a vehicle for H. suis infections 
in humans.  
Consumption of pork is particularly prominent in Europe, and the prevalence of H. suis 
infections in pigs at slaughter age is 60% or more (Haesebrouck et al., 2009) and pork 
carcasses were shown to be frequently contaminated (Chapter 2). Therefore, one might 
assume that the prevalence of H. suis infections in humans is also expected to be high. 
However, in Chapter 3, the prevalence of NHPH-infections among 118 patients suffering 
from severe gastric upset was reported to be lower than 1%, which correlates with previous 
studies conducted in Western countries (Hilzenrat et al., 1995; Mention et al., 1999; Ierardi et 
al., 2001; Boyanova et al., 2007; Iwanczak et al., 2012). Only a single patient was diagnosed 
with H. suis infection in recent studies performed by our team (Joosten et al., 2013). This 
apparently low prevalence at present in Europe may be in contrast with other parts of the 
world. In China and Thailand, the presence of NHPH in gastric biopsies was shown 2% and 
6%, respectively, in patients suffering from severe gastric upset (Yali et al., 1998; Yang et al., 
1998). Recently, Liu et al. (2014) showed that NHPH infections are common among Chinese 
patients co-infected with H. pylori, with H. suis being the most prevalent NHPH species, 
infecting 6.94% of all H. pylori-positive patients. Although coinfections with H. pylori and 
NHPH species have previously been described by other researchers, some authors suggested a 
negative correlation between H. suis and H. pylori colonization (De Groote et al., 2005; Ojano 
et al., 2012; Yakoob et al., 2012; Martin et al., 2013). Whether or not the higher occurrence 
reported in Asian countries originate from a higher colonization capacity among Asian strains, 
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could be due to an underestimation in European countries, or could be inherent to the food 
culture and cultural food processing activities is unclear and could be the aim of future studies.  
2. The role of slaughter in the spread of H. suis through the meat supply chain 
Using qPCR, H. suis DNA was detected on dressed pork carcasses (Chapter 2), which adds 
strength to the hypothesis of H. suis transmission through pork consumption. No 
differentiation between viable or dead bacteria was made during this study, since the time 
span between collection of the carcass samples and processing of these samples was a limiting 
factor, which could render false negative results. The shoulder and chest area were the two 
most frequently contaminated regions on the carcasses. We therefore hypothesize that carcass 
contamination is either caused by spilling stomach content after cutting the esophagus at 
evisceration or, more likely, during splitting, when the splitting saw reaches the mouth of the 
pigs, that may already be contaminated by regurgitation as pigs are secured upside down. 
Although in theory, the carcass splitter should be disinfected with water at 82°C between each 
carcass, this procedure is not always feasible in practice. The water used is, however, 
frequently at a lower and ineffective temperature (Botteldoorn et al., 2004; De Sadeleer et al., 
2008). Moreover, in many slaughterhouses a mechanical carcass splitter is used, which is not 
disinfected in between each carcass. 
In order to control carcass contamination, it is crucial to first identify the sources and 
routes of contamination throughout the slaughter process. The current study however, did not 
aim to identify the exact route(s) of (cross-)contamination. Future studies are needed to assess 
the role of the different steps at slaughter and their impact on carcass contamination. This can 
be achieved by following individual pigs from the lairage area up until the respective 
carcasses hanging in the chilling room. Taking samples of the same pig, does not only allow 
to identify risk points along the slaughter line, but also to study the genotypic diversity of H. 
suis in the slaughterhouse. Again, the low success rate of H. suis isolation has hampered 
research, by narrowing the options in the development of a genotyping method. Only recently, 
a multilocus sequence typing (MLST) method, allowing typing of H. suis directly in stomach 
samples, was developed (Liang et al., 2013). Employing this technique, the authors revealed 
that H. suis is a genetically heterogenic bacterial species. In addition, strain typing was 
applied to four H. suis strains colonizing human patients, which showed a very close 
relationship to porcine H. suis strains. (Liang et al., 2013; Flahou et al., 2015, personal 
communications). The same technique was successfully applied in the present study to 
characterize H. suis from five selected mouth swab samples at the slaughterhouse (chapter 2). 
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Five different sequence types (STs) were identified and within samples derived from the same 
pig herd, two or three different STs were found. Although only a low number of H. suis was 
examined, the high diversity on carcass level might indicate contamination of carcasses does 
not originate from the slaughter environment and agrees with the previous findings of Liang 
et al. (2013) concerning the high diversity at pig herd level. On the contrary, MLST analysis 
was not successfully applied to a selection of the dressed carcass swabs. Most probably, this 
was due to the low concentration of H. suis DNA obtained from the sponge samples. 
Therefore, no comparison between genotypes of H. suis bacteria present in the mouth could 
be made with those present on the carcasses. At this stage, for example, it is unclear whether 
positive mouth and/or lymph node samples originating from one pig can be related to 
contaminated contiguous pig carcasses along the slaughterline. Therefore, whether or not 
there is a causal linkage between the contamination of carcasses and the mouth or lymph 
nodes of successive pigs remains unclear.  
In a similar study design, investigating the prevalence of Salmonella contamination at 
slaughter, a contaminated lairage area was shown to be related to positive carcasses after 
polishing, before opening the belly of the pig (De Busser et al., 2011). Several authors have 
emphasized the role of the lairage pens in (cross)contamination of Salmonella on pork 
carcasses due to re-shedding by carrier animals under stressful conditions (Hurd et al., 2001; 
De Sadeleer et al., 2008; De Busser et al., 2011). Measures taken during slaughter procedures 
in avoidance of fecal contamination not only reduce the spread of Salmonella on pig carcasses, 
but have shown to drastically limit Campylobacter contamination on pork meat as well 
(Borch et al., 1996). Both pathogens, however, are associated with the porcine intestine and 
are primarily shed in the faeces. Since at this moment, there are no indications for fecal 
transmission of H. suis in pigs, we believe this pathway is of less importance in carcass 
contamination. 
3. Feasibility of developing a diagnostic test based on serology 
Many serological tests are available for the diagnosis of H. pylori infections (Vaira et al., 
1999; Burucoa et al., 2013; Formichella et al., 2013). In contrast, no such test identifying 
antibodies against NHPH species in blood of humans or animals is available yet.  
Several techniques can be applied for antibody detection. Most tests are based on 
enzyme-linked immunosorbent assay (ELISA) formats, using whole cell lysates or purified 
antigens (Vaira et al., 1999). Latex agglutination tests have been demonstrated to be more 
suitable as near patient tests, because they are technically simple to perform and provide a 
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result within minutes. Only recently, a highly sensitive and specific line immunoassay based 
on recombinant H. pylori proteins, which are known to be involved in virulence, colonization, 
and immune evasion, was developed (Formichella et al., 2013). The main advantage of this 
test principle over ELISA, is the possibility of a separate application of different single 
antigens, which allows screening for diverse virulence factors from different H. pylori strains. 
Overall, the performance of serology is highly dependent on the choice of antigens. The 
antigens used should not cross-react with proteins of other bacterial species in order to 
increase the specificity. Moreover, they should be highly conserved in different strains of the 
same species to be applicable in different patient populations. In Chapter 3, a small H. suis 
GGT subunit was identified to elicit an immune response only in NHPH-infected humans, 
holding promise as a potential target protein for the differentiation of gastric NHPH infections 
from H. pylori infections. Furthermore, in the present study H. suis rUreB and rNapA were 
recognized by the serum of one H. pylori infected patient and a H. suis infected patient, but 
not by the serum of a H. heilmannii infected patient. The proteins identified during this study 
seem to be appropriate targets to be included in a serological test kit, since they do not react 
with sera from non-infected patients. Moreover, according to their function and to previously 
performed genome sequence analysis (Vermoote et al., 2011), these proteins are probably 
highly conserved among different H. suis strains. Therefore, by combining the small GGT 
subunit in a multiplex protein array with H. suis rUreB and rNapA, the development of a H. 
suis-specific serological test might be feasible. Further research on variations in these antigens 
amongst H. suis strains is however necessary. Furthermore, the clonal makeup and 
composition of an individual‟s immune system depends both on genetic and environmental 
factors, which in turn can lead to complexities in standardizing a serological test. Therefore, at 
this moment the major challenge in the development and validation of such a test consists of 
collecting a sufficient number of sera from human patients infected with H. suis and other 
gastric Helicobacter species. 
4. Future perspectives 
From the results of the present and other recent research, some perspectives to future work 
can be formulated. First of all, the prevalence of H. suis during different stages at the 
slaughterhouse and the environmental factors contributing to H. suis contamination of pig 
carcasses should be further examined. Possible environmental factors contributing to the 
survival of H. suis bacteria include the presence of a moist environment, a low oxygen tension 
and the ability to form biofilms.  
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A sequence library representing the genetic diversity among H. suis strains colonizing the 
stomach of humans, might enable to comprehend whether certain H. suis strains are more able 
to jump from pigs to humans than others. A comparative genome analysis of these strains 
with the those present on pork carcasses, might further elucidate the true importance of pork 
consumption in the transmission of H. suis infections. Strain typing without the need for prior 
cultivation has been made possible by the development of an MLST technique (Liang et al., 
2013). At the moment, the biggest obstacle remains the acquirement of a sufficient number of 
H. suis isolates from humans. 
The applicability and suitability of H. suis rGGT, rUreB and rNapA in diagnostic assays, 
determining the presence of antibodies in human sera, should be further evaluated. Since a 
negative correlation between H. suis and H. pylori colonization has been proposed and a 
steady decline in H. pylori prevalence in Western society has been observed (Martin et al., 
2013; Dore et al., 2015), H. suis infections might emerge in the future, which in turn again 
emphasizes the need for a species-specific serologic test. 
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Since the discovery of Helicobacter (H.) pylori infections and their association with gastric 
diseases in humans, many new gastric Helicobacter species have been described. These so-
called gastric non-Helicobacter pylori (NHPH) species are believed to primarily colonize the 
stomach of domesticated and wild animals. Meanwhile, 5 NHPH species have been found to 
colonize the human stomach as well, causing gastritis, gastric ulcers and gastric cancer. H. 
suis is regarded to be the most prevalent NHPH species in the gastric mucosa of humans 
suffering from gastric disease. H. suis is a Gram-negative, spiral-shaped bacterium that 
colonizes the stomach of the majority of slaughter pigs worldwide. In pigs, H. suis infections 
have been associated with ulcers of the gastric non-glandular mucosa, chronic gastritis and a 
decrease in daily weight gain. Pigs are considered the main source of H. suis infection for 
humans. The exact routes of H. suis transmission to humans, however, remain unclear. Since 
close contact with animals seems to be the most obvious manner for humans to contract 
NHPH infections, it is remarkable that pig-related species are more prevalent in humans than 
those species associated with cats or dogs. This might indicate that other routes, such as the 
consumption of contaminated pork, may contribute to the transmission of H. suis infections to 
humans as well. Therefore, the first aim of this thesis was to determine the potential of pork as 
a source of H. suis infection for humans. 
First, the presence of viable H. suis bacteria in retail pork was determined. Since 
isolation and cultivation of H. suis is a very laborious process with a low success rate, 
detection of viable H. suis bacteria in pork by using culture-based methods is not feasible. In 
order to determine whether pork constitutes a possible source of H. suis infections for humans, 
a non-culture dependent, quantitative detection method allowing differentiation of viable from 
dead H. suis bacteria in pork had to be developed. In chapter one, the elaboration of a protocol 
for pork sample treatment with ethidium monoazide (EMA) in combination with qPCR was 
described. After validation on experimentally contaminated pork, this EMA qPCR was 
applied to 50 retail pork samples. In two of these pork samples, DNA derived from viable H. 
suis bacteria was detected, demonstrating the presence of low concentrations of viable 
bacteria. Sequence analysis of the positive PCR products confirmed the presence of H. suis 
DNA. Using the same technique, the persistence of H. suis bacteria in experimentally 
contaminated pork was established for at least 48 h. In conclusion, consumption or 
manipulation of contaminated pork may constitute a new route of transmission for H. suis 
infections in humans.  
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The main goal addressed in chapter two, was to determine the occurrence of H. suis on 
pork carcasses during slaughter practices. In two consecutive studies, samples were taken at 
different stages of slaughter (scalding water, head and mouth swabs, mesenteric lymph nodes, 
palatine tonsils and on the chest, shoulder and ham region of pork carcasses) in three 
slaughterhouses, and examined for the presence of H. suis, using qPCR. H. suis DNA was 
detected in all slaughterhouses, in 8.3% of all 1083 samples. In the first study, H. suis DNA 
was detected in 10% of the head swabs (n: 90), 14.4% of the mouth swabs (n: 90) and 13.3% 
of the mesenteric lymph nodes (n: 90). In order to elucidate whether true colonization occurs 
in the lymph nodes, the presence of H. suis DNA was assessed at the mesenteric lymph nodes 
of 24 pigs after 4 weeks of experimental infection. Despite high-level colonization of the 
porcine stomachs with the H. suis strain, no H. suis DNA was detected in the mesenteric 
lymph nodes. This might indicate that its presence in the mesenteric lymph nodes of 
slaughtered pigs is due to contamination during the slaughter process, or that longer infection 
periods are necessary for the colonization of lymph nodes. No H. suis DNA was detected in 
the palatine tonsils and scalding water samples taken at three different slaughterhouses.  
In the second study, H. suis DNA was detected in all five dressed pork carcass areas, 
with the mouth and chest being the two most frequently contaminated areas pre-chilling and 
the shoulder and chest the two most frequently contaminated areas post-chilling. 
Contamination levels of dressed pork samples did not exceed 184 genomic equivalents per 
100 cm
2
 (shoulder, ham) or 300 cm
2
 (chest). All positive PCR products were subjected to 
sequence analysis of the ureA gene, confirming the identification of H. suis DNA. Using 
multilocus sequence typing (MLST) on five selected samples, a high diversity among the 
strains derived from the same pig herd (and all slaughtered in the same abattoir) was 
demonstrated. In conclusion, we demonstrate a relatively high presence of H. suis on pork 
carcasses. To which extent the consumption of contaminated pork contributes to the 
transmission of H. suis infections from pigs to humans remains unclear. Furthermore, the 
current study does not identify the exact route(s) of carcass contamination during the 
slaughter process. These considerations might encompass the focus of future studies. 
Various tests for the diagnosis of H. pylori infections are readily available. In contrast, 
the focal distribution of NHPH bacteria in the human stomach and the very fastidious nature 
of these species often hamper the diagnosis of these infections in humans. At present, no test 
for the detection of antibodies against H. suis, or NHPH-species in general, in blood samples 
of humans or animals is available. In order to obtain the knowledge needed to develop an H. 
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suis-specific serological diagnostic test, H. suis-specific antigens that are recognized by 
antibodies of infected human patients need to be identified. The second aim of this thesis, was 
therefore to identify H. suis antigens which could be of value in future serological diagnosis 
of H. suis infections in humans (chapter three). For this purpose, two approaches were used. 
In a first series of experiments, H. suis-specific antigens which are recognized by sera of 
infected patients, were identified by performing two-dimensional gel electrophoresis of H. 
suis proteins, which were probed with sera from human patients infected with H. suis, H. 
heilmannii or H. pylori. In a second approach, the reaction of these sera was studied, using 
one-dimensional gel electrophoresis (followed by immunoblotting) of H. suis proteins urease 
subunit B (UreB), neutrophil-activating protein A (Nap A) and gamma-glutamyl 
transpeptidase (GGT).  
During the first approach, nine immuno-reactive protein spots between ~20kDa and 
~30kDa and at ~60kDa (which were recognized by serum from a H. suis infected patient, but 
not by serum from patients infected with other Helicobacter species) were selected for further 
identification. For each of these spots, however, the identification by LC-MS/MS led to the 
correspondence of more than one protein on the same position in the gel.  
In our second approach, immunoreactivity to all three selected H. suis proteins was 
observed. In previous studies H. suis GGT was shown to be synthesized as a precursor 
enzyme of ~60 kDa, with subsequent processing into a large (~40 kDa) and a small subunit 
(~20 kDa). During the current study, the small subunit (20 kDa) of H. suis rGGT was 
recognized by sera of H. suis or H. heilmannii infected humans, but not by sera from H. pylori 
infected patients. In contrast, reactivity was only observed at ~60 kDa for the serum samples 
of all included H. pylori infected patients. Reactivity for the very same protein was observed 
after applying the serum of the H. suis infected patient as well, while for the H. heilmannii 
infected patient, no immunoreaction was observed. For H. suis rUreB, a marked reactivity 
was detected in the serum sample of the H. suis infected patient and the serum sample of one 
H. pylori infected patient. For H. suis rNapA, reactivity was detected in the same serum 
samples as for rUreB.  
Combining H. suis rGGT in a multiplex protein array with H. suis rUreB and rNapA, 
might therefore allow the development of a H. suis-specific serological test. Such test will 
have to be validated by comparing the antibody binding patterns of sera from several H. suis 
infected, NHPH infected and H. pylori infected patients and of sera from healthy humans.
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Sinds de ontdekking van Helicobacter (H.) pylori infecties en hun associatie met 
maagaandoeningen bij de mens, werden verschillende nieuwe gastrale Helicobacter species 
beschreven. Deze zogenaamde gastrale non-Helicobacter pylori Helicobacter (NHPH) 
species koloniseren voornamelijk de maag van gedomesticeerde en wilde dieren. Ondertussen 
werd reeds voor 5 NHPH species aangetoond dat ze ook de maag van de mens kunnen 
koloniseren en gastritis, maagulcera en maagkanker kunnen veroorzaken. H. suis wordt 
beschouwd als de meest frequent voorkomende NHPH species bij mensen met 
maagaandoeningen. H. suis is een Gram negatieve, spiraalvormige bacterie die wereldwijd de 
maag van de meerderheid van de slachtvarkens koloniseert. Bij varkens worden H. suis 
infecties geassocieerd met maagulcera ter hoogte van het non-glandulaire deel van het 
maagslijmvlies, chronische gastritis en een daling van de dagelijkse gewichtstoename. 
Varkens worden beschouwd als de belangrijkste bron van H. suis infecties voor de mens. Het 
is onduidelijk hoe de mens besmet wordt met H. suis. Aangezien nauw contact met dieren de 
meest voor de hand liggende manier is voor het oplopen van NHPH infecties, is het 
opmerkelijk dat de varken-gerelateerde species, H. suis, vaker voorkomt bij de mens dan 
Helicobacter species die vooral met katten of honden geassocieerd worden. Dit kan erop 
duiden dat ook andere routes een rol zouden kunnen spelen in de overdracht van H. suis 
infecties naar de mens. Hierbij kan onder andere gedacht worden aan overdracht via besmet 
varkensvlees. Het eerste doel van deze thesis was dan ook nagaan of varkensvlees een 
potentiële bron van H. suis infecties voor de mens kan zijn. 
In een eerste studie werd de aanwezigheid van levende H. suis bacteriën bepaald in 
varkensvlees. Aangezien isolatie en cultivatie van H. suis een zeer moeizaam proces is met 
een lage kans op slagen, is de detectie van levende H. suis bacteriën in varkensvlees met 
behulp van cultuur-afhankelijke methodes niet haalbaar. Om te bepalen of varkensvlees een 
mogelijke bron vormt voor H. suis infecties bij de mens, was er dus nood aan een cultuur-
onafhankelijke, kwantitatieve detectiemethode, die toelaat een onderscheid te maken tussen 
levende en dode H. suis bacteriën in varkensvlees. In hoofdstuk één wordt de uitwerking van 
een dergelijke methode beschreven. Hierbij werd gebruik gemaakt van ethidium monoazide 
(EMA) in combinatie met qPCR. Na validatie op experimenteel besmet varkensvlees, werd 
deze EMA qPCR methode toegepast op 50 stalen varkensgehakt dat aangekocht werd in 3 
verschillende winkels. In twee van deze 50 stalen werd DNA afkomstig van levende H. suis 
bacteriën gedetecteerd, waarbij lage concentraties aan levende bacteriën werden aangetoond. 
De aanwezigheid van H. suis DNA werd bevestigd door middel van sequentieanalyse van de 
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positieve PCR producten. Met behulp van EMA qPCR werd bovendien aangetoond dat H. 
suis bacteriën gedurende ten minste 48 uur overleven in experimenteel besmet varkensvlees. 
Als conclusie kan gesteld worden dat consumptie of manipulatie van besmet varkensvlees een 
mogelijke bron van H. suis infecties kan zijn voor de mens. 
In hoofdstuk twee werd het voorkomen van H. suis op varkenskarkassen tijdens het 
slachtproces nader onderzocht. In twee opeenvolgende studies werden in drie slachthuizen 
stalen genomen tijdens verschillende stadia van het slachtproces (broeibakwater, kop en muil 
swabs, mesenteriale lymfeknopen, tonsillen en ter hoogte van de borst, schouder en ham regio 
van varkenskarkassen). Deze werden onderzocht op de aanwezigheid van H. suis DNA, met 
behulp van qPCR. H. suis DNA werd teruggevonden in alle slachthuizen en dit in 8,3% van 
de 1083 onderzochte stalen. In de eerste studie werd H. suis DNA aangetoond in 10% van de 
kop swabs (n: 90), 14,4% van de muil swabs (n: 90) en 13,3% van de mesenteriale 
lymfeknopen (n: 90). Om na te gaan of echt kolonisatie optreedt in de lymfeknopen, werd de 
aanwezigheid van H. suis DNA onderzocht in de mesenteriale lymfknopen van 24 varkens, op 
4 weken na een experimentele H. suis infectie. Niettegenstaande een hoge graad van H. suis 
kolonisatie werd vastgesteld ter hoogte van de maag van de varkens, werd geen H. suis DNA 
gedetecteerd in de mesenteriale lymfeknopen. Dit kan erop wijzen dat de aanwezigheid van H. 
suis DNA in de mesenteriale lymfknopen van geslachte varkens het gevolg is van 
contaminatie tijdens het slachtproces. Het is evenwel ook mogelijk dat de mesenteriale 
lymfeknopen pas gekoloniseerd worden op een later tijdstip na infectie. Er werd geen H. suis 
DNA teruggevonden in de tonsillen en het broeibakwater. 
Gedurende de tweede studie, werd H. suis DNA gedetecteerd ter hoogte van alle vijf 
de bemonsterde zones op het varkenskarkas. De muil en borst waren de frequentst 
gecontamineerde zones voor het koelen. Na koeling, werd H. suis DNA het frequentst 
aangetoond ter hoogte van de schouder en borst. Het aantal genomische equivalenten dat werd 
gedetecteerd in de karkasstalen bedroeg niet meer dan 184 per 100 cm
2
 (schouder, ham) of 
300 cm
2
 (borst). Alle positieve PCR producten werden onderworpen aan een sequentieanalyse 
van het ureA -gen, waarbij de identificatie van H. suis DNA werd bevestigd. Met behulp van 
“multilocus sequence typing” (MLST) op vijf geselecteerde stalen, werd aangetoond dat in 
hetzelfde slachthuis, diverse H. suis stammen kunnen aanwezig zijn op karkassen afkomstig 
van dezelfde varkensstapel. Als conclusie kan gesteld worden dat H. suis DNA frequent kan 
aangetoond worden op varkenskarkassen. De mate waarin consumptie van besmet 
varkensvlees bijdraagt tot de overdracht van H. suis infecties naar de mens blijft onduidelijk. 
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Bovendien kan op basis van de resultaten bekomen tijdens de huidige studie, niet nagegaan 
worden hoe karkassen exact besmet worden tijdens het slachtproces. Dit zou het onderwerp 
van toekomstige studies kunnen uitmaken. 
Voor de diagnose van H. pylori infecties zijn diverse laboratoriumtesten beschikbaar. 
Het stellen van de diagnose van een infectie met NHPH species bij de mens is daarentegen 
veel moeilijker. Dit is onder andere te wijten aan de zeer focale kolonisatie van NHPH 
bacteriën in de maag, waardoor deze kiemen niet altijd terug te vinden zijn in een biopt dat 
genomen wordt tijdens gastroscopie. Ook testen die gebaseerd zijn op de urease activiteit van 
deze kiemen kunnen om dezelfde reden een vals negatief resultaat geven. Bovendien zijn 
gastrale NHPH bacteriën bijzonder moeilijk te kweken in het laboratorium en voor sommige 
species zoals H. suis, is isolatie vanuit stalen van mensen tot nu toe nog niet gelukt. Op dit 
moment is er ook geen test beschikbaar die toelaat om antistoffen tegenover H. suis of andere 
NHPH species aan te tonen in het bloed van mensen of dieren. Een eerste stap in de 
ontwikkeling van een dergelijke test, is de identificatie van H. suis-specifieke antigenen, die 
worden herkend door antilichamen van geïnfecteerde patiënten. Dit vormde de derde 
doelstelling van deze thesis (hoofdstuk 3). Voor dit doel werden twee benaderingen gevolgd. 
In een eerste reeks van experimenten werden H. suis-specifieke antigenen, die herkend 
worden door antistoffen in het serum van geïnfecteerde patiënten, geïdentificeerd via twee-
dimensionale gelelektroforese van H. suis eiwitten, gevolgd door immunoblotting. Voor deze 
toepassing werd gebruik gemaakt van sera afkomstig van patiënten besmet met H. suis, H. 
heilmannii of H. pylori. In een tweede benadering werd de reactie van deze sera bestudeerd 
tegenover drie recombinant aangemaakte H. suis eiwitten, namelijk urease subunit B (UreB), 
neutrofiel-activerend eiwit A (NAP-A) en gamma-glutamyl transferase (GGT). Hierbij werd 
gebruik gemaakt van één-dimensionale gelelektroforese, gevolgd door immunoblotting.  
Tijdens de eerste benadering, werden negen immuno-reactieve proteïne spots 
geselecteerd tussen ~ 20kDa en ~ 30kDa en ter hoogte van ~ 60kDa. Het betrof hier spots die 
herkend werden door het serum van een met H. suis geïnfecteerde patiënt, maar niet door 
serum van patiënten geïnfecteerd met andere Helicobacter species. Door toepassing van 
massaspectrometrie werd evenwel aangetoond dat elk van deze spots meerdere eiwitten 
bevatte.  
In de tweede reeks experimenten, werd immunoreactiviteit tegen elk van de drie 
geselecteerde recombinante H. suis eiwitten waargenomen. Uit eerdere studies blijkt dat het H. 
suis GGT gesynthetiseerd wordt als een precursor enzyme van ~ 60 kDa dat nadien gesplitst 
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wordt in een grote (~ 40 kDa) en een kleine subeenheid (~ 20 kDa). Tijdens de huidige studie 
werd de kleine subeenheid (~ 20 kDa) van het H. suis rGGT herkend door sera van patiënten 
die besmet waren met H. suis of H. heilmannii, maar niet door sera van met H. pylori 
geïnfecteerde patiënten. Voor de serumstalen van de met H. pylori geïnfecteerde patiënten 
werd enkel reactiviteit ter hoogte van ~ 60 kDa waargenomen. Hetzelfde eiwit werd eveneens 
herkend door het serum van de met H. suis besmette patiënt, maar niet door het serum van de 
met H. heilmannii besmette patiënt. Het H. suis rUreB werd herkend door antistoffen in het 
serumstaal van de met H. suis besmette patiënt en het serumstaal van één patiënt die besmet 
was met H. pylori. Voor H. suis rNapA werd reactiviteit waargenomen bij gebruik van 
dezelfde serumstalen als voor rUreB.  
Deze resultaten kunnen erop duiden dat door het combineren van H. suis rGGT met H. 
suis rUreB en rNapA in een multiplex protein array, de ontwikkeling van een H. suis-
specifieke serologische test mogelijk is. Deze test moet dan gevalideerd worden met sera 
afkomstig van niet besmette mensen en met sera van patiënten die besmet zijn met met H. suis, 
andere NHPH en H. pylori. 
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aanpak en eigen invalshoek op mijn studies en manuscripten hebben me meer dan eens 
nieuwe inzichten gebracht. Bedankt voor de fijne samenwerking!  
De leden van de lees- en examencommissie, Prof. dr. D. Maes, Dr. D. De Groote, Prof. 
dr. L. Andersen, Prof. dr. R. Ducatelle, Prof. dr. P. Deprez, Prof. dr. L. Maes, alsook de 
voorzitter van de examencommissie, Prof. dr. E. Claerebout wens ik te bedanken voor hun tijd 
en inzet om dit proefschrift grondig na te lezen en van opbouwende kritiek en suggesties te 
voorzien. Thank you, Prof. Andersen, for flying over from Denmark to attend my PhD 
defense. I‟m honoured! 
Professor Ducatelle, uw enthousiasme en interesse voor het onderzoek ontgaat 
niemand. Dank u wel voor uw hulp, raad en ideeën, ik heb ze steeds als een extra motivatie 
ervaren. 
Zonder financiële steun was dit onderzoek niet mogelijk. Graag had ik daarom de 
Federale Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu en 
in het bijzonder Dr. D. Vandekerchove, Celhoofd Contractueel Onderzoek DVZ, bedankt 
voor de ondersteuning van dit project en voor het vertrouwen. Mijn dank gaat ook uit naar de 
Universiteit Gent en haar onderzoeksraad, voor ondersteuning van het Helicobacter 
onderzoek.  
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Prof. dr. Martel, An, jij was de eerste die “iets” in me zag. Dankzij jou zette ik mijn 
eerste stappen in het labo. Het ging zoals je verwachten kan met je eerste passen: met vallen 
en opstaan… Jouw motivatie en gedrevenheid, evenals het vertrouwen dat je in me stelde zal 
ik echt nooit vergeten. Bedankt. Ook aan Tom, Lieven, en An G. een dikke merci om me 
zoveel bij te leren! 
Dr. Van Steendam, Katleen, bedankt voor de inwijding in de immunoproteomics en de 
fijne samenwerking die daarop volgde. Ik wens je het allerbeste toe, in en naast het onderzoek. 
Ik wil ook graag het team van de dienst gastro-enterologie van het AZ Maria 
Middelares, met in het bijzonder Dr. Vanderstraeten en Katrien De Bosschere, bedanken. 
Dankzij jullie interesse en motivatie maakten we van de klinische studie waaraan we samen 
werkten een succes. 
Ons team groeide de afgelopen jaren enorm. Zo zag ik er zelf nieuwe gezichten bij 
komen en andere dan weer vertrekken… Bram, een vaste waarde in het team: Je hebt me de 
afgelopen jaren van heel nabij gevolgd, want al was je op papier geen promotor, in de praktijk 
was je dat des te meer. Een oprechte dankjewel voor je heldere kijk op mijn experimenten en 
resultaten, me te helpen bij mijn schrijfsels en het team te verbinden! En wat de laatste avond 
in HelsingØr betreft: die serenade hebben we nog tegoed van jou…  
Annemieke, ambitieus als je bent, inspireer je iedereen in je omgeving... Bedankt voor 
je woorden van raad wanneer ik het nodig had en de hilarische beschrijvingen van wat je 
soms meemaakt met je kinderen. Eens goed kunnen lachen, en daarna er weer volop tegenaan 
is de sfeer die jij meebrengt in wat ik tot voor kort “onze” bureau mocht noemen. Ook mijn 
andere bureaugenoten verdienen een extra woord van dank. Marleen, ik vroeg me vaak af 
waar ik zou beginnen met je te bedanken. Dus begin ik bij het begin. Onze eerste “echte” 
ontmoeting: Toen ik het bureau, dat ik met jullie zou delen, voor het eerst binnenstapte en 
vroeg van wie die paardenkalender aan de muur was... De start van een reeks gedeelde 
interesses en passies, de start van een echte vriendschap. Merci dus voor alles. Het klinkt niet 
veel, maar betekent des te meer! Chloë, terwijl mijn doctoraatsonderzoek op zijn einde liep, 
was het jouwe net goed gestart. Je hebt alvast een goede start gemaakt. Nog veel succes 
gewenst! Melanie, we spraken elkaar vaak moed in met: “Iedereen komt op zijn pootjes 
terecht…” En het is nog waar ook. Ik wens je alle geluk en succes toe! 
Ellen, Myrthe, Caroline, Iris, Eva, Hannah, Chloë: veel succes met jullie verdere 
studies en bij het schrijven. Ik kom graag luisteren naar jullie verdediging als jullie er klaar 
voor zijn! To my Chinese colleagues, I wish you the very best of luck! 
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Nathalie, dit was echt “ons” project. Bedankt voor je inzet, je oog voor detail, alsook 
om er de humor in te houden in minder amusante situaties... Ik heb enorm graag met je 
samengewerkt! Sofie, dankzij jouw manier van aanpakken en toewijding voor het team, gaat 
het vooruit in het labo. Bedankt!  
Miet… Hoe langer je weg bent uit Melle, hoe vaker ik aan je denk. Een vriendin zien 
vertrekken is dan wel niet fijn, maar ze opzoeken des te meer! Vanaf dag 1 klikte het tussen 
ons, en werden we niet alleen collega‟s, maar ook echt vriendinnen. Ik zal trouwens nooit 
Bert‟s gezicht vergeten toen hij ons stond op te wachten aan het station en we van Antwerpen 
kwamen met jouw “lieslaarzen” bij de hand.  
Pascale, mijn buur(t)vrouw, merci voor de opkikkers (haha) wanneer ik het nodig had, 
alsook voor je degelijke beschrijving in “doctoreren voor dummies”… 
Aan alle (oud-)collega‟s van de vakgroep: Humor en hulpvaardigheid is wat jullie 
allen verbindt. Ik ga jullie missen. Jo en Gunter, mijn dag begon steeds met jullie 
“Goeiemorgen.” Ik kon altijd terecht bij jullie voor hulp, alsook voor een grapje… De trap 
op… En terug een vrolijke noot van Elin of Koen, een helpende hand van Serge en Arlette 
aan de routine. Een glimlach en een woord van moed bij de koffie van Marc, Maxime, Lien, 
Evelien, Venessa, An G, Ilse, Mark, Tom, Gunther, Connie, Roel, Gwij of Lieze. Ook aan de 
collega‟s die de vakgroep eerder verlieten en de collega‟s van pathologie: bedankt voor de 
fijne tijd! Nele, mijn herinneringen aan het werk op de farmacie zouden alvast niet zo fijn zijn, 
had ik dat werk niet samen met jou gedeeld! Ik wens je alle geluk en succes toe voor de 
toekomst. Christian, Delphine, Sarah, dankjewel om mijn “petieterige” staaltjes zo mooi te 
verwerken. En dat steeds met de glimlach! 
Ook al zullen ze het nooit begrijpen… Aan alle dieren die hun leven met het mijne 
delen of deelden: ook jullie zijn het, en niemand anders, waarom ik de studies tot dierenarts in 
de eerste plaats aanvatte. Vandaar dat jullie hier dan ook niet mogen ontbreken. 
Lieve vrienden en familie, na weken van afwezigheid meld ik met trots dat “Chez 
Linus” binnenkort terug de ovens opstart en de deuren opent... En daarna gaan we dansen! 
Geert en Marianne, reserve-pa en –ma, jullie moeten gedacht hebben “nog studeren?” 
toen ik met mijn plannen op de proppen kwam. Merci voor alle steun en dan vooral die onder 
de vorm van jullie oudste zoon. Hij is zonder meer het beste dat me ooit overkomen is! 
Mijn twee zussen, dank je wel om er altijd voor me te zijn. Liesbeth, het doet me wel 
iets, te weten dat je fier bent op je “kleine” zus. Sanne, dikke merci voor de prachtige kaft! 
Want zeg nu zelf, elk boek wordt toch voor het eerst beoordeeld aan zijn kaft. Bedankt ook 
voor de welkome ontspanning onder de vorm van ontbijtjes en taartjes (inclusief lachsalvo‟s), 
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alsook je boeken. De intro van “De laatkomer” vergeet ik nooit meer (allez, dat hoop ik dan 
toch…Of ik moet dement geworden zijn, zoals het hoofdpersonage ).  
Amélie en Astrid, mijn lieve nichtjes: Bedankt voor de leuke vertelsels en grappige 
spelletjes (samen zullen we vast nog veel denkbeeldige aapjes redden en brandjes blussen met 
onze “muiltjes” aan). “Missie volbracht, high-five, tante Lien” hoor ik al galmen... 
Papa, mama, de leeftijd waarop ik dit doctoraat behaal, staat gelijk met de leeftijd 
waarop jullie jullie levens volledig afstemden op de komst van jullie kinderen. Van zodra we 
er waren, stond alles in „t teken van ons geluk en onze toekomst. En dat is nooit meer 
veranderd. Alle eer en lof van vandaag is dus eigenlijk voor jullie! “Bedankt!”, ik kan het echt 
niet vaak genoeg zeggen, “Bedankt!” 
Tom, dé man in mijn leven, ook al verdien je het nog het hardst van iedereen, toch 
geen “gestoef” voor jou... Dat heb ik je beloofd. Enkel nog deze laatste zin. Ook zoals ik je 
heb beloofd: “Voor Rémy, opdat je nog veel wortels kan eten!”  
Het belang voor onderzoek naar maagaandoeningen bij de mens was voor mij nooit 
veraf. Na een onophoudende strijd verloor mijn grootvader het oneerlijke gevecht tegen 
maagkanker. Het spijt me tot op de dag van vandaag dat ik hem nooit gezegd heb hoe moedig 
ik hem wel vond. Graag had ik dit doctoraat dan ook opgedragen aan hem.  
  
 
  
  
 
